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The elderly are at risk for impaired nutritional status due both to dietary intake and
to physiological changes. Approximately five to six percent of the elderly residing in
nursing homes are malnourished due to low or marginal dietary intake. The elderly may
also have changes in nutritional requirements secondary to disease conditions (Kerstetter
et al., 1992).
The elderly have been reported to have dietary intakes lower than the
Recommended Dietary Allowances for micronutrients as well as macronutrients (Payette
and Gray-Donald, 1991b). Sahyoun et ale (1988) reported that the elderly consume less
than the Recommended Dietary Allowances for zinc and B-vitamins. Hematological
indices (albumin, prealbumin and transferrin levels) also are reported to be lower in
elderly populations than in younger populations. Lower dietary intakes of trace minerals
including zinc have been found in both sexes, especially in the institutionalized elderly
(Sahyoun et al., 1988).
Data from the Second National Health and Nutrition Examination Survey
(NHANES IT) reported that mean serum zinc values changed with age, being relatively
low during childhood, increased during adolescence, peaked in young adulthood and then
declined in older and elderly adults (pilch and Senti, 1985). Turlund et ale (1986)
reported a lower absorption of zinc in elderly men than in younger men which may reflect
a lower requirement of absorbed zinc by the elderly. Plasma zinc is frequently reported as
an indicator of zinc status (King, 1990). Plasma zinc was reported to be a useful
indicator of the exchangeable zinc pool size. Decreased plasma zinc reflected a loss of
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zinc from bone and liver and, thus, indicated an increased risk for development of
metabolic and clinical signs of zinc deficiency (King, 1990). With increasing age, zinc
status may be affected due to changes in the regulation of zinc metabolism. Wastney et al.
(1992) reported that zinc taken up by red blood cells decreased with age. The response of
plasma zinc to a zinc load of 100 mg per day was 115 percent in 80 year old subjects as
compared to 55 percent in 20 year old subjects. In addition, the excretion of zinc in urine
was over five-fold greater in the older subjects than in the younger subjects. Perhaps this
excess excretion of zinc in urine is due to increased release of zinc from red blood cells.
Analysis of NHANES II data showed that almost 35 percent of the total US
population took vitamin and mineral supplements regularly. In addition, supplement use
was more common among older adults. Supplement use was reported to be higher
among older women than older men (Koplan et al., 1986; Looker et al., 1988).
However, a downward trend in supplement use has recently been reported by Bender et
al. (1992) from data comparing the 1980 Food and Drug Administration study and the
1986 National Health Survey. This analysis revealed that supplement use among adults
decreased significantly from 42 percent in 1980 to 38 percent in 1986. Nevertheless,
other studies reported that supplement use was high among older adults (Bender et al.,
1992).
Individuals self-reporting health problems have been reported to be more likely to
use supplements. In a cohort study, Kim et al. (1993) reported that the elderly as a group
were regular supplement users. Those persons on specialized diets were greater users
than those on unrestricted diets. Nevertheless, no evidence was found for an association
between supplement use and decreased mortality. However, Read et al. (1989) reported
that the majority of supplement users believed that supplements decreased the
susceptibility to and/or severity of health problems. Additional fmdings were that those
who consumed nutrient supplements also consumed diets which were adequate in the
nutrient(s) being supplemented (Payette and Gray-Donald, 1991b).
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The excess intake of supplements is of great concern with respect to trace mineral
interactions. One of the trace element interactions of significance in human nutrition is the
negative effect of excess zinc on copper bioavailability (O'Dell,1989). Plasma zinc is
responsive to zinc supplementation. In a 28-day zinc supplementation study that provided
30 mg per day to elderly subjects, plasma zinc concentration increased by 25 percent, but
did not affect the platelet and leukocyte zinc content (Swanson et al., 1988).
Zinc supplementation has been shown to affect plasma zinc and indicators of
copper status in both young and old men and women. Boukaiba et al (1993) reported that
in elderly subjects serum zinc concentration increased by 20 percent after supplementing
with 20 mg of zinc per day. A reduction in serum copper concentration was reported due
to the negative effect of zinc supplementation. In adult females, zinc supplementation
resulted in decreases in copper-zinc superoxide dismutase and serum ferritin which are
indicators for copper and iron status, respectively. Use of iron with zinc lessened the
effect of zinc on iron status (Yadrick et al., 1989).
The interaction between zinc and copper may be a reciprocal one, since low
plasma zinc with zinc deficiency is often accompanied by high plasma copper (Tumlund,
1988). Copper deficiency was observed when a therapeutic level (150 mg/day) of
supplemental zinc was used over an extended period (Prasad et al., 1978). In a case
study of a male with sickle cell anemia who previously received 220 mg of zinc sulfate
three times a day for seven months followed by 110 mg six times a day for 2 years,
Prasad et ale (1978) reported a correction of hypocupremia, microcytosis, and increased
leucocyte and neutrophil count with copper supplementation. Similar effects although to a
lesser extent were observed with dietary zinc. Fischer et ale (1981) suggested that dietary
zinc exerted its antagonistic effect by producing a copper binding ligand making copper
unavailable for absorption. However, no effect was observed on iron status measures.
Rossander-Hulten et ale (1991) reported that high dietary zinc did not interfere with iron
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absorption, but manganese in the meal inhibited iron absorption suggesting a competitive
inhibition by manganese on iron absorption.
Iron supplementation was also found to have a negative effect on serum zinc.
Newhouse et ale (1993) reported that a therapeutic dose of 320 mg of elemental iron
resulted in a downward trend in serum zinc and magnesium concentrations from the
supplementation phase to the discontinuation phase. The values at 18 and 24 weeks were
significantly lower than baseline concentrations.
The alteration of trace mineral status in the elderly, the interactive properties of
trace minerals and the increased use of supplements supports the need for research to
investigate the effects of supplementation on mineral status measures in elderly. The
present study examined the zinc, copper, and chromium supplementation effects on trace
minerals in plasma.
Purpose and Objectives
The purpose of this study was to detennine the effect of zinc, copper, and
chromium supplementation on zinc, copper, manganese and iron status in
hypercholesteremic adults.
The following objectives were fonnulated for this study:
1. To detennine trace mineral (iron, copper, zinc and manganese)
concentrations in plasma in hypercholesteremic adults.
2. To detennine the effect of trace mineral supplementation on the status indicators of
zinc, copper, iron and manganese.
3. To detennine the relationship between initial levels of zinc, copper, manganese
and iron and the concentrations of these minerals in plasma during
supplementation.
4. To detennine the effects of withdrawal of supplements on measures of trace
mineral status in hypercholesteremic adults.
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Hypotheses
1. There will be no significant effect of chromium supplementation on status
measures of zinc.
2. There will be no significant effect of chromium supplementation on status
measures of copper.
3. There will be no significant effect of chromium supplementation on status
measures of iron.
4. There will be no significant effect of copper supplementation on status measures
of zinc.
5. There will be no significant effect of copper supplementation on status measures
of copper.
6. There will be no significant effect of copper supplementation status measures of
iron.
7. There will be no significant effect of zinc supplementation on status measures of
zinc.
8 . There will be no significant effect of zinc supplementation on status measures
copper.
9. There will be no significant effect of zinc supplementation on status measures of
iron.
Assumptions
1. It was assumed that the subjects consumed the supplements as per the directions.
2. It was assumed that the subjects fasted 12 hours before every blood collection.
3. It was assumed that the subjects did not alter their eating habits during the study
period.
4. It was assumed that the subjects completely reported food intake and that these
records reflected usual eating practices.
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Limitations
1. Accuracy of the dietary records were limited to the ability of the subjects to
estimate and record their food intake, and to the ability of researchers to interpret
and code data.
2. The Food Processor Plus 5.03 used for the dietary analysis only estimated the
intake of certain nutrients and does not contain values for chromium.
3. The sample group was not representative of the entire population; thus, the results
are applied to this sample group only.




This chapter includes reviews of research related to assessment of the nutritional
status of the elderly, particularly related to certain trace elements. Supplement use among
the U.S. population with emphasis on the trace mineral supplement use among the elderly
is reviewed. In addition, reviews of the biochemical roles of zinc, copper, and chromium
and their assessment measures are included. Trace mineral interactions of zinc/copper
and zinc/iron are also included. Included in the methodological reviews are dietary and
anthropometric assessments.
Supplementation
Extent of Supplement use
Vitamin and mineral supplements are widely used in the United States. The 1987
National Health Interview Survey (NHIS), a collaborative study of the National Center
for Health Statistics and the National Cancer Institute, reported that 51.1 percent of adults
aged 18 to 99 years in the United States consumed a vitamin/mineral supplement in 1986,
and 23.1 percent consumed supplements daily. The results of this study also suggested
that there has been a change in supplementation practices since the 1970's. The most
commonly used supplements in 1986 were multivitamins followed by vitamin C,
calcium, and vitamins E and A (Subar & Block, 1990). In the reports from the Second
National Health and Nutrition Examination Survey (NHANES II) data almost 35 percent
of US population between 18 and 74 years of age took vitamin/mineral preparations
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regularly. These supplementation practices were more common among older adults than
younger people. The use of supplements was positively associated with older ages, high
income, higher education level and white race (Koplan et al., 1986; Looker 1988).
Garry et al. (1982) conducted a 5-year longitudinal study on 304 elderly men and
women over the age of 60 years living in the area of Albuquerque, NM. Fifty-five
percent of the men and 61 percent of the women in this group ingested one or more
vitamin or mineral supplements regularly. The supplemental intake of this sample
population of elderly was higher compared to supplemental data obtained from national
studies. Payette and Gray-Donald (1991a) reported that 43 percent and 62 percent of
elderly Canadian men and women, respectively, consumed vitamin and/or mineral
supplements during the preceding year.
Nutrient supplements were consumed for a variety of reasons. Bender et al.,
(1992) compared the 1980 Food and Drug Administration Vitamin and Mineral
Supplementation Survey and the 1986 National Health Interview Survey. The results
revealed that supplement use varied with the number of physical conditions. Use of
supplements was directly proportional to the number of conditions. Nevertheless,
supplement use was higher among individuals who considered their health to be excellent
or very good rather than good, fair or poor (Bender et al., 1992).
In a cohort study, Kim et al., (1993) examined the relationship between the
reported use of vitamin and mineral supplements and mortality. Between 1982 and 1984,
they reinterviewed surviving members from the NHANES I study. At the baseline, the
mean age was 50.2 years, and the subjects were followed for a period of 13 years. The
use of supplements was highest among the oldest group, 65-74 years. More often,
supplement usage was noted among persons on a special diet or who were alcoholics.
Although subjects reported that they used supplements for health benefits, the authors
concluded that supplement use was not associated with decreased mortality. In contrast,
Read et al. (1989) assessed health status and food and nutrient beliefs using a
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questionnaire. The results indicated that older individuals of ages 60-70 and above who
were occasional and/or regular vitamin/mineral supplement users rated their health as
excellent The respondents of a supplement usage study by Park et al. (1991) also agreed
that supplements reduced their susceptibility to and/or the severity of health problems.
Zinc Supplementation
In 1980, an estimated 13.5 percent of U.S. adults consumed nutrient supplements
containing zinc. The mean intake from these supplements was fifty percent of the RDA.
However, many individuals consumed zinc at levels approaching three times the RDA for
this nutrient (Stewart et al., 1985). Zinc had been used therapeutically to correct other
mineral deficiencies. Prolonged supplementation (2 years) with high levels of zinc (150-
200 mg/day) in a patient with sickle cell anemia resulted in hypocupremia which was later
corrected by copper supplementation (Prasad et al., 1978).
Biochemical and Physiolo~icalRoles of Zinc
Zinc plays a important role in certain physiological conditions. Maternal zinc is
essential for nonnal growth of the fetus (Keen et al., 1993). There is a progressive
decrease in plasma zinc during the gestation period which is not influenced by zinc intake
(Hambidge et al., 1983). In a study in which pregnant women received multivitamin-
mineral supplements containing 30 mg of zinc gluconate, plasma zinc decreased
suggesting an increased requirement for zinc by the mother and by growth of fetus. They
also reported an increase in polymorphonuclear zinc and a decrease in polymorphonuclear
copper. Plasma zinc concentrations of the fetus were higher than maternal plasma zinc
concentrations (Hambidge et al., 1983).
Depressed zinc status was reported among people with eating disorders. McClain
(1992) suggested that zinc deficiency may be a sustaining factor for abnonnal eating
behavior. Serum and 24-hour urinary zinc values were lower than normal in these eating
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disordered patients. Serum zinc was significantly depressed in individuals with bulimia
and anorexia nervosa compared to healthy controls. Upon supplementation with 25
mg/day of zinc, serum zinc concentration and urinary zinc increased. In addition,
hemoglobin and hematocrit concentrations decreased in supplemented groups. Dietary
zinc intake was also reported to be lower for individuals with bulimia and anorexia
nervosa prior to supplementation.
Zinc supplementation increased plasma zinc in patients with chronic inflammatory
rheumatic disease. Supplementation with 45 mg of zinc (as zinc gluconate) led to an
increase in plasma zinc from baseline concentrations. Nevertheless, there were no
changes in erythrocyte or leucocyte zinc concentrations (Peretz et al., 1993).
Zinc supplementation might cause side effects. Side effects of zinc
supplementation such as headaches, abdominal cramps, nausea, loss of appetite and
vomiting were registered at concentrations of 50 mg of elemental zinc consumed over 12
weeks (Samman and Roberts, 1987).
Trace Mineral Status in Elderly
Zinc Status
Dietary Intake
The Recommended Dietary Allowance for zinc for males and females aged 51 and
over are 15 and 12 mg/day, respectively (National Research Council, 1989). Nationwide
surveys have provided information on dietary zinc intake of the people of all age groups.
Dietary zinc intake for elderly has been reported to be less than two-thirds of the
Recommended Dietary Allowances (Howarth, 1989; Dreosti, 1984; Greger, 1977 and
Hutton and Hayes-Davis, 1983).
Several national and small studies reported a reduced intake of zinc in
populations. Moser-Veillon studied the data from the Food and Drug Administration's
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Total Diet Study, the U.S. Department of Agriculture's Nationwide Food Consumption
Survey of individuals, and a year-long Beltsville diet study. She indicated that adult
males selected diets containing 90 percent of the RDA for zinc, whereas, women selected
diets containing less than 81 percent of the RDA for zinc. These data were from elderly
between the ages of 60-65 years. According to the Total Diet study, women aged 60 to
65 years consumed a mean of 8.7 mg of zinc per day, and in men of the same age mean
consumption was 12.9 mg per day (Pennington and Young, 1991).
Harland et ale (1980) analyzed the mineral content of adult diets based on
published data from USDA's 1965 Household Food Consumption Survey. At an intake
of 2,800 Kcal, zinc intake was 89 percent of the Recommended Dietary Allowance.
When zinc intake was assessed based on the commodity group (market basket), the intake
was 18.7 mg/day.
Zinc intake was reported to be lower in institutionalized Australian individuals
between the ages of 60-99 years compared to independently living elderly (Flint et al.,
1981). This study reported that institutionalized elderly consumed 7.6 ± 1.1 mg zinc
whereas controls (non-institutinalized) consumed 11.0 ± 0.5 mg per day. Dietary intake
of institutionalized elderly was also studied by Greger (1977). Both men and women had
intakes of less than two-thirds of the RDA.
Several studies were perfonned to assess zinc intake and nutriture of non-
institutionalized elderly. Fosmire et ale (1984) studied zinc intake in rural elderly
individuals 65 years and older. The mean zinc intake of the whole sample was 9.8 ± 3.1
mg per day. The mean zinc intake of males and females was 11.6 ± 4.2 and 9.0 ± 2.2
mg per day, respectively. For the total group, the mean zinc intake was 5.87 mg/1000
kcal. The nutrient density for males and females was 5.98 and 5.81 mg per 1000 kcal.
Bogden at ale (1987) studied the zinc nutriture in non-institutionalized elderly subjects
aged 60-89 years. The dietary intake was found to be less than the RDA for both men
and women, with a mean daily intake of 10.1 mg and 7.9 mg, respectively.
12
Greger and Sciscoe (1977) studied the zinc nutriture of elderly participants of an
urban feeding program. From one-day dietary records they found that the mean daily
dietary intake for men and women was 10.2 and 9.9 mg, respectively. In a study on
elderly Canadian women (58-89 years) on intake of zinc, Gibson et ale (1985) reported
that the mean intake was 7.6 mg/day.
The data from the above studies indicated a lower zinc intake in women compared
to men. From the literature it can be concluded that dietary zinc intake in both
institutionalized and non-institutionalized elderly is below the RDA. In addition, elderly
women consumed less dietary zinc compared to men of the same age group.
Biochemical Measures of Zinc
Reduced zinc concentrations in plasma and other tissues have been reported in
older adults (Pilch and Senti, 1985; Thomas et al., 1988; Wastney et al., 1992). Serum
zinc concentrations, the only biochemical assessment of zinc status measured in
NHANES IT, changed with age and gender. Values were significantly higher in males
(89.6 ± 0.53 ug/dL) than in females (84.0 ± 0.40 ug/dL). In males, the concentrations
were low during childhood (80.6 ±0.64 ug/dL), increased during adolescence (87.8 ±
0.71 ug/dL), peaked in young adulthood (93.0 ± 0.61 ug/dL), and then declined in older
adults (89.1 ± 0.63 ug/dL) and in the elderly (85.6 ± 0.79 ug/dL). The authors
suggested that the decrease could be due to a decreased release of zinc from erythrocytes
with age (Pilch and Senti, 1985).
Several studies reported reduced plasma or serum zinc concentrations in females
compared to males. Mean serum zinc was measured in elderly males with a mean age of
78 years and females with a mean age of 82 years. Younger subjects aged 22 years
served as controls in this study. Mean serum zinc was significantly lower in
independently living elderly males (mean 15.0 umol/L) compared to younger males (mean
17.24 umol/L). Mean serum zinc in elderly females was lower (mean 14.18 umol/L) than
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younger females (15.36 umoVL), although these were not significantly different. Thus,
irrespective of sex, serum zinc concentrations were lower in older compared to younger
subjects. In addition, both younger and older males had higher serum zinc concentrations
than women. However, this gender difference was significant only between the younger
controls (Rea, 1989). Goode et ale (1991) found a similar trend in serum and plasma
zinc. They found plasma zinc to be lower in both healthy (10.8 umoVL) and hospitalized
elderly (10.5 umoVL) compared to a younger control group (12.7 umoVL).
Due to the reduced dietary zinc intake in the elderly, mild zinc deficiency appears
to be a significant clinical problem. Lindeman et ale (1971) measured plasma zinc
concentrations in males (20-84 years) and females (20-58 years). A significant decrease
in plasma zinc concentration with increasing age was reported in both males and females.
However, plasma zinc concentrations were found to be significantly lower in males than
in females. The authors did not report the concentrations; however, they gave regression
equations to calculate plasma and red cell concentrations for males and females of
different age groups based on the plasma zinc concentration in micrograms per deciliter.
Bunker et ale (1984a) conducted a zinc metabolic balance study with twenty-four
healthy elderly people aged 69.7 to 85.5 years. Individuals younger than the study
group served as controls. Elderly males had plasma zinc concentration of 10.9 umoVL as
compared to 11.0 umoVL in females. The plasma zinc concentrations of the elderly as a
whole group was significantly lower (11.0 ± 1.2 umoVL) than the younger controls (13.0
± 1.8 umoVL). These results suggested that there is a significant difference between the
age groups in plasma zinc concentrations. However, no significant differences were
reported in whole blood and leucocyte zinc concentrations between elderly and young
adults (Bunker et al., 1984a).
Plasma zinc response to the same zinc load was reported to be higher in older than
younger subjects indicating a change in zinc metabolism with age (Wastney et al., 1992).
This kinetic study assessed changes in zinc metabolism with age in healthy adults aged
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20-84 years after giving a single oral or intravenous bolus of 65zinc. The study consisted
of two consecutive 9 month periods. The first period consisted of a nonnal diet
containing 10 mg of zinc/day; the second period consisted of a nonnal diet with 10 mg of
zinc and an additional 100 mg zinc/day orally. Plasma zinc concentration increased due to
zinc loading (100 mg/day) over the basal concentration in both older and younger
subjects. This response was significantly related to age with the response being higher in
older than younger subjects. Plasma zinc and urinary zinc were used in regression
equations to estimate absorption. Zinc excretion was fivefold greater in older than in
younger subjects. In another study by Bales et al. (1986), plasma response to the same
zinc load was reported to be lower in elderly compared to younger subjects. The elderly
(mean age 72.5 years) and the younger controls (mean age 24 years) were given 25 mg of
zinc orally as zinc gluconate and plasma zinc was measured at 0, 1, 2, 3, and 4 hours
post dose. At 2 and 3 hours, mean plasma zinc concentrations were significantly lower in
elderly than in younger subjects. Total area under the response curve was significantly
lower for elderly than for younger, subjects suggesting a reduced uptake of zinc in elderly
compared to the young. This difference in response to zinc load could be due to a small
dose of 25 mg compared to 100 mg in the study conducted by Wastney et al. (1992). In
addition, this dose was given one time, compared to the nine months of supplementation
by Wastney et al. (1992).
Zinc utilization changes with age. A 30 day metabolic study with elderly subjects
aged 56-83 years showed a negative zinc balance upon zinc supplementation with either
7.80 or 23.26 mg of zinc in addition to 6.03 mg of dietary zinc (Burke et al., 1981).
Thus, a total of 29.09 mg of zinc still led to a negative balance in these elderly subjects.
Zinc intake did not affect zinc retention. However, in another study, 15 mg of zinc fed in
a metabolic study was sufficient to maintain balance in men aged 65 - 74 years (Turnlund
et al., 1981).
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Food consumption also seems to affect plasma zinc concentration. Plasma zinc
concentrations decline with the intake of a meal. In a study of premenopausal women
aged 37 ± 8 years, Wallock et ale (1993) studied the response of plasma zinc to meal
trials. Seventeen hour fasting increased plasma zinc concentrations by 9 percent from
12.5 ±0.44 to 13.6 ±0.6 umol/L. Plasma zinc concentrations decreased by 11 percent
from 12.7 ± 0.3 to 11.3 ± 0.2 umol/L in one meal trial compared to 18.5 percent decrease
from 12.6 ±0.4 to 10.6 ±0.2 umol/L in three meal trial. However, erythrocyte and
erythrocyte membrane zinc did not change significantly with meal feeding (Wallock et al.,
1993). Couzy et al (1993) did not find any effect of diet on zinc absorption in elderly
subjects aged 70 to 83 years. A stable isotope label (0.8 mg 70Zn) was added to a test
meal of high or low zinc bioavailability based on phytic acid content. Their results
showed that aging did not lead to nutritionally relevant changes in zinc absorption nor in
the effects of dietary inhibition of zinc absorption. Serum zinc concentrations did not
differ between these elderly subjects and younger controls. Thus, the ability to absorb
zinc seems to be preserved in healthy elderly people, at least until 80 years of age.
However, a study by Turnlund et ale (1986) suggested a decreased absorption of zinc
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young men (22-30 yr) and six elderly men (65-74 yr) in a 12 week metabolic study. The
purified formula diet supplemented with selected food items contained 15 mg of zinc per
day was fed. Serum, urinary, and fecal zinc, and zinc balance was determined by atomic
absorption spectrophotometry. Zinc absorption was significantly less in elderly at 17
percent compared to younger men at 31 percent suggesting decreased zinc absorption
with age.
Zinc absorption responds to changes in dietary zinc. In a 75-day metabolic study
on young men, absorption was 25 percent when 16.5 mg zinc was fed. Zinc absorption
increased to 53 and 49 percent after 13 and 42 days, respectively, when 5.5 mg zinc was
fed. However, total zinc absorption decreased from 4.1 to 2.78 mg/day during low zinc
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period (Wada et al., 1985). Even though the percent absorption is greater with low zinc
diet, the total amount absorbed is also reduced and may compromise zinc status.
Plasma and serum zinc
There is currently no specific sensitive laboratory or functional indicator for zinc
status. There is little functional zinc reserve in the body. The body's zinc concentrations
are maintained by both conservation and redistribution of tissue zinc. In mild zinc
deficiency, conservation is manifested by reduction or cessation of growth in growing
organisms and by reduced excretion in mature organisms (King, 1990).
Plasma zinc frequently has been used to assess zinc nutriture by detennining
circulating zinc concentrations (Solomons, 1979). Plasma zinc responds to supplemental
zinc intake. Field et al. (1987) supplemented elderly individuals with 50, 100, and 150
mg of elemental zinc daily for 28 days. As a result, plasma zinc increased with the 100
and 150 mg/day doses in these individuals. Supplementation of 100 mg of zinc led to a
significant increase in plasma zinc from baseline (10.31 ± 2.38 umoVl) to the end of the
study (11.98 ± 2.43 umo1/1). Similarly, a significant increase in plasma zinc was
reported due to supplementation with 150 mg of zinc/day from baseline (11.83 ± 1.70
umol/l) to the end of the study (17.76 ± 5.15 umo1/1).
Zinc nutriture is reflected through plasma and serum zinc. Experimental zinc
deficiency induced in human volunteers was accompanied by a progressive decrease in
circulating zinc (Baer & King, 1984; Hess et al., 1977). A 10-week confmed metabolic
study was perfonned on six healthy young male volunteers by Baer and King, (1984).
Subjects were fed a semisynthetic liquid diet providing only 0.28 mg of zinc/day during a
5-week depletion period. This was followed by a repletion period during which only
three of the subjects were fed zinc at levels of 6.0, 23.2, or 46.3 mg per day. A
significant decrease in plasma zinc was reported from pretreatment (89 ± 17 ug/l00g) to
end of the depletion period (50 ±20 ug/l00g). During a one week repletion period,
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plasma zinc increased by 260 percent. The increase was significant from 36 ±21
ug/l00g to 93 ± 5 ug/l00 g. However, the increase after an additional week of repletion
was not significant (Baer and King, 1984).
In another study zinc excretion under conditions of negligible zinc intake (0.17
mg/day) was measured in women taking a combination oral contraceptive agent (+OCA)
and in women with nonnal menstrual cycles (-OCA). In this 35 day study, serum zinc
dropped significantly by 47 percent (from 84.5 ± 11.1 ug/dL to 44.9 ± 12.7 ug/dL) in the
+OCA group and by 21 percent (from 80.8 ± 14.4 to 63.5 ±22.3 ug/dL) in the -OCA
group. A significant decline in urinary zinc was also reported in both groups. Urinary
zinc declined to 83 (0.06 mg/day) and 62 percent (0.15 mg/day) in both the +OCA and
-OCA groups. Subjects in both groups had initial urinary zinc excretion within the
nonnal range (140 - 780 ug/day). It was noted that the higher the initial level of zinc in
urine, the greater the decline during the study. Although not significant, mean urinary
zinc was lower in the +OCA group compared to the -OCA group. Whole body zinc
losses as measured by urinary and fecal zinc were similar for both groups. These data
suggested that accessible zinc stores are not extensive, and the depletion of storage zinc
due to a low-zinc diet results in a decrease in serum zinc (Hess et al., 1977).
Decreases in serum zinc concentrations was observed in patients receiving total
parenteral nutrition without trace mineral supplementation (Fleming et al., 1976). Serum
zinc was monitored from 3-13 weeks in patients receiving total parenteral nutrition.
Three out of eight patients showed a significant decline in serum zinc to less than 70
ug/dL for at least 2 consecutive weeks. Further decline in serum zinc was found in three
patients after resumption of oral zinc.
Effect of Protein on Zinc
Dietary protein has been positively associated with zinc absorption (Sandstrom et
al., 1980, 1989). Several metabolic studies were conducted to study the effect of protein
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on zinc. Zinc absorption from a composite meal was studied in adult women by
Sandstrom et ale (1980). Zinc absorption from a meal with bread was measured with a
radionuclide technique using 65zinc and whole-body counting. The bread was prepared
from 100 and 72 percent extraction wheat and enriched with zinc chloride. A significant
positive correlation was found between zinc absorption and protein content Total zinc
absorption from white bread containing 0.4 mg zinc was significantly lower than from
wholemeal bread containing 1.3 mg zinc.
Another study was conducted to investigate the effects of increasing levels of
various protein sources on zinc absorption from a legume-based meal. The basal test
meal consisted of cooked white beans (35 grams of dry wt), 100 g of white bread and
tomato sauce. The basal diet contained 15 g of protein and 25 umol of zinc. The protein
level was increased to approximately 20 and 30 g by adding protein sources such as
chicken, fish, beef, or milk: products. One test meal had 44 g protein. The results
indicated that the amount of zinc absorbed from the meals was positively correlated with
protein and zinc content Zinc absorbed from the basal meal with the lowest protein
content was 5.9 ± 1.7 umol, and zinc absorption increased to 10.3 ±2.0 umol from the
test meal with chicken (doubled protein content and low zinc). However, zinc absorption
was even higher at 15.9 ±4.7 umol from the diet with the addition of beef (doubled
protein content and high zinc). These differences in zinc absorption were significant.
Thus, the authors concluded that the zinc content of the main protein source affects zinc
absorption (Sandstrom et al., 1989). Similar results were observed in rats (Hunt and
Johnson, 1992).
Greger and Snedeker (1980) conducted a 51 day balance study using adult males
to investigate the effect of different levels of protein on zinc status. There were four
treatments with high and low levels of protein and phosphorus. The low and high protein
consisted of 8.1 g and 24.1 g of nitrogen respectively. The moderate and high
phosphorus diets contained 1,010 mg and 2,525 mg of phosphorus. Subjects on high
19
protein diets lost significantly more zinc in the urine compared to subjects on low protein
diets. However, phosphorus level did not affect urinary zinc. Subjects fed high protein
diets had higher serum zinc concentrations, and protein was positively correlated with
zinc losses. Colin et al. (1983) found a similar effect of protein on zinc absorption in
females. They studied the effect of protein on fecal zinc levels in a metabolic balance
study. The study consisted of four periods of 6 hours each. Subjects were fed moderate
and high protein in combination with low or high zinc. Similar to the findings of Greger
and Snedeker (1980), they also found significantly greater urinary losses in subjects
consuming high protein diets (0.38 ± 0.12 mg/day) compared to subjects fed low protein
diets (0.27 ± 0.12 mg/day). However, zinc retention was not affected by protein level.
No significant differences were found in fecal zinc excretion with intake of 50 g or 100 g
of protein per day (Colin et al., 1983).
Similarly, no effect of protein on fecal zinc was reported by Mahalko et al. (1983)
from a metabolic balance study. Male volunteers (19-64 years) participated in this study.
Subjects were fed two different diets containing 65 and 94 g of protein with similar
mineral composition. Both diets contained approximately 7 mg of zinc. Similar to the
other studies, subjects on high protein diet had significantly higher urinary zinc losses
compared to the subjects on low protein diet (Mahalko et al., 1983).
Zinc and Serum Alkaline Phosphatase
Alkaline phosphatase is a zinc metalloenzyme found in bone, placenta, and
intestine. Elevated concentrations were found in conditions involving increased
deposition of calcium in bone and certain liver diseases. Low alkaline phosphatase
concentrations usually are not clinically significant (Lee and Neiman, 1993; pg 244).
Increased alkaline phosphatase activity was demonstrated in response to zinc
supplementation in adults and young children. Adult pregnant women receiving 15 mg of
supplemental zinc (zinc sulfate) daily during pregnancy had higher alkaline phosphatase
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activity compared to non-supplemented controls (Hambidge et al., 1983). In another
study by Udomkesmalee et ale (1992) young children aged 6-13 years supplemented with
25 mg of zinc/day for six months also had significantly increased alkaline phosphatase
activity over baseline.
Studies have shown that serum alkaline phosphatase concentrations vary with
season. McKenna et ale (1985) studied vitamin D status in relation to alkaline
phosphatase concentration in elderly Irish people. A higher serum alkaline phosphatase
was found in vitamin D depleted groups compared to vitamin D replete group. In
addition, they also found a decrease in serum alkaline phosphatase activity with seasonal
rise in 25-hydroxyvitamin D levels. Thus it was hypothesized that serum alkaline
phosphatse varies with seasons, the values being lower in summer compared to winter.
Copper Status
DietaIy Intake
The Food and Nutrition Board recommends 1.5 to 3.0 mg of copper a day as a
safe and adequate range of dietary intake for adults (National Research Council, 1989).
Klevay et ale (1979) conducted a metabolic ward study on 13 men consuming a variety of
typical U.S. diets. To replace fecal and urinary losses, they found 1.3 mg of copper/day
were needed. However, Turnlund et ale (1981) found copper intakes at a level of 3 mg a
day fed in a metabolic study were sufficient to maintain copper balance in elderly men
aged 65-74 years.
Studies have shown inadequate dietary intake in both institutionalized and non-
institutionalized elderly. According to the Total Diet Study, women aged 60 to 65 years
had a copper intake of 0.86 mg per day as compared to 1.18 mg for men, aged 60 to 65
years (Pennington and Young, 1991). In another study conducted to assess the dietary
copper intake of elderly of age range 65-69 years (Howarth, 1989), a self-completed
semi-quantitative food frequency questionnaire was used to collect the dietary intake
21
infonnation. The mean dietary copper intake for men was 1.9 mg, and 1.74 mg/day for
women. Both the men and women consumed' below two-thirds of the ESADDI for
copper.
Bogden et al. (1987) reported copper intakes below the Estimated Safe and
Adequate Daily Dietary Intake (ESADDO for copper in elderly men and women aged 60-
89 years recruited from a senior citizen center. Consumption of copper for men was
between 1.17 mg and 1.33 mg, and for women between 0.86 mg and 1.19 mg per day.
In a metabolic balance study, copper levels in self-selected diets of subjects aged 14 to 64
years were analyzed by atomic absorption spectrophotometry (Holden et al., 1979). Each
subject was asked to maintain a fourteen-day food record for the items eaten as well as the
linear measure, volume, and weight Infonnation about brand names and recipes were
also recorded. Foods and beverages were collected separately without contamination.
Homogenized food was used for analyses. The mean daily copper intake was below 2
mg/day. The majority (81 percent) of the subjects consumed less than two-thirds of this
recommended amount. However, there was no significant difference in copper intake
between men (1.2 mg/day) and women (0.9 mg/day). The mean copper:calorie ratio for
both males and females was 0.50 mg per 1,000 kcal as compared to the suggested 0.85
mg per 1,000 kcal. Thus, diets supplying adequate amounts of energy do not guarantee
adequate levels of copper (Holden et ~., 1979). Bunker et al. (1987) also reported lower
copper intakes in house-bound elderly consuming self-selected diets.
In institutionalized elderly copper intake was also reported to be below the
ESADDI (Pennington and Young, 1991; Dreosti et al., 1984; Thomas et al., 1988;
Howarth, 1989). Thomas and co-workers (1988) conducted dietary analyses of twenty-
one patients in a geriatric rehabilitation unit with a mean age of 81.7 years. The food
intake for a period of five days was reproduced exactly including the hospital meals,
sweets, medicines, and any food brought by the visitors. Leftover food was collected as
"rejects" and used for analysis. Food was collected in trace mineral free plastic
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containers. Blood was collected between 09.00 and 10.00 hours. The meals provided 18
umol (1.14 mg) of copper if consumed completely. This amount was significantly less
than the ESADDI for this age group.
Biochemical Measures of Copper Status
Serum copper and ceruloplasmin concentrations are frequently used by
researchers as indicators of copper status. Age and sex influence serum copper
concentration (Yuncie et al., 1974). A significant increase in serum copper was observed
with increasing age in male subjects, ranging in age from 20 to 89 years. However, this
effect was not observed in females of the same age range. Age had no effect on serum
ceruloplasmin concentrations, but the concentration was higher in females than in males.
Bunker et al. (1984a) conducted a metabolic balance study using elderly subjects,
76 to 78 years of age, with a younger group as controls. Duplicates of self-selected diets,
feces, and urine were collected over a 5-day period into trace mineral free containers. The
mean copper concentrations in blood for men and women were 17.8 and 20.7 umol/L
respectively. Mean serum ceruloplasmin was 330 ±80 mgIL for the elderly subjects
compared to 310 ±55 mgIL for the control group; however these concentrations were not
significantly different. Mean plasma copper concentrations of the elderly were
significantly higher (19.4 ± 3.4 umol/L) compared to younger controls (16.4 ± 2.4
umol/L).
The amount of copper in the diet can affect copper absorption. August et al.
(1989) studied copper absorption from natural diets containing 3 mg of copper in young
and elderly men and women. Copper absorption was 60 percent in younger subjects and
53 percent in the older ones. Absorption increased to 67 percent in older individuals
when a diet low in copper (0.5 mg) was given.
Serum ceruloplasmin was used as an indicator of copper status in copper-
supplemented rheumatoid arthritis (RA) patients by DiSilvestro et al. (1992). Twenty-
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three RA patients age range 35-53 years received medication to treat their disease.
Healthy adults served as controls of this study. Subjects and controls were supplemented
with 2 mg of copper for a period of four weeks. Copper supplementation resulted in a
significant increase in erythrocyte copper superoxide dismutase in both patients and
controls. Supplementation did not have any significant effect on serum ceruloplasmin in
either group; although, arthritic patients had significantly higher serum ceruloplasmin
concentrations at both pre-supplementation (41 ± 10 mg/dL) and post-supplementation
(43 ± 16 mg/dL) compared to controls at pre-supplementation (29 ±7 mg/dL) and at
post-supplementation (29 ±9 mg/dL). The hypothesis for this difference in serum
ceruloplasmin concentrations was that arthritis patients have marginal copper status, and
ceruloplasmin synthesis is higher due to inflammation. In addition, the dosage and
duration of supplementation may have been too low and too short to have a significant
effect on serum ceruloplsamin. A similar non-response of ceruloplasmin to copper
supplementation was reported by Pratt and coworkers (1985) in nonnal adult subjects.
Their study was a double-blind placebo trial with seven subjects with mean age of 42
years. Subjects either received a placebo or 10 mg of copper/day as copper gluconate for
12 weeks. Supplementation did not have any significant effect on serum, urine, or hair
copper concentrations. The urinary copper was 126 ±22 ug/l00 ml before copper
supplementation; and 123 ± 16 ug/l00 ml after supplementation. Serum and hair copper
concentrations were not provided by the authors. However, the lack of response could
be explained by the fact that the sample size was too small to detect any effect due to
supplementation. (Pratt et al., 1985)
Chromium Status
DietaIy Intake
The current recommendation of the Food and Nutrition Board is 50 to 200 ug
chromium per day (National Research Council, 1989). Studies estimating chromium
24
intake in the United States reported lower intakes than the Estimated Safe and Adequate
Daily Dietary Intake (ESADDO (Offenbacher et al., 1986; Anderson and Kozlovsky,
1985; Bunker et al., 1984b).
Several metabolic studies assessed the chromium intake of adults. Anderson and
Kozlovsky (1985) conducted a metabolic study using adults of (20-65 years) in
Beltsville, Maryland. Duplicates of self-selected diets were collected for a period of
seven days. The homogenized samples were analyzed by atomic absorption
spectrophotometry. Average analyzed daily chromium intake was 33 ug and 25 ug for
males and females, respectively. Lower chromium intake of females could be due to
females' lower total energy intakes although the chromium density was greater in females
than in males. Caloric intake of males and females was 2,300 and 1,600 Kcal,
respectively.
Similar results were obtained from another metabolic study on the elderly.
Offenbacher et ale (1986) conducted a metabolic study using two elderly nonna! male
subjects aged 62 and 66 years. They were placed in a metabolic unit for 12 days (two 6-
day periods). Subjects' diets were analyzed using atomic absorption spectrophotometry.
The average dietary chromium intake of the two subjects was 36.9 and 36.7 uglday,
respectively, which was below the ESADDI.
Bunker and co workers (1984b) conducted a metabolic balance study on healthy
elderly people ranging in age from 70 and 85 years, eating self-selected diets. Ashed
duplicate diets were analyzed by atomic absorption spectrophotometry. The mean daily
chromium intake for males and females was 29.8 uglday and 20.1 uglday, respectively.
The intake was below the Estimated Safe and Adequate Daily Dietary Intake for
chromium.
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Biochemical Measures of Chromium Status
Reported plasma chromium concentrations of the elderly are not different from
young adults. Offenbacher (1992) reviewed different research studies on chromium
including, supplementation trials, monitoring studies, balance studies, and animal
studies. She suggested that chromium retention decreases with age suggesting an altered
chromium metabolism.
The effect of chromium supplementation on chromium status was studied by
Anderson and co-workers (1985) using adult subjects (21-69 years). Subjects were
given either a placebo or 200 ug of inorganic chromium (chromium chloride) daily for 3
months in a double-blind cross-over study. After three months of supplementation serum
chromium significantly increased three-fold from 0.13 ±0.02 ng/ml to 0.38 ±0.02
ng/ml. However, serum chromium was not significantly different between males and
females.
Chromium absorption from meals with chromium content found in typical U.S.
diets was inversely related to dietary intake. The 7-day average intake from self-selected
diets of adults was well below the minimum suggested safe and adequate intake.
Anderson and Kozlovsky (1985) studied chromium metabolism in adults (25-65 years)
consuming self-selected diets. Duplicates of food and beverages were collected daily for
a period of seven days. An inverse relationship between chromium absorption and
chromium in the diet was found. Absorption at a dietary intake of 10 ug was
approximately two percent and absorption further decreased to 0.5 percent from an intake
of 40 ug. However, urinary chromium excretion was not related to dietary chromium
intake. Fecal chromium was not measured in this study (Anderson and Kozlovsky,
1985).
The effect of chromium supplementation on urinary chromium excretion was
reported by Anderson et ale (1982). Supplementation with 200 ug of chromium for 2
months resulted in a significant increase in urinary chromium. Subjects had a mean initial
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urinary chromium concentration of less than 0.3 ng/ml which increased significantly to
1.02 ng/ml after two months of supplementation. However, an additional month of
supplementation did not further significantly increase urinary chromium. The non-
supplemented subjects had significantly lower urinary concentration compared to
supplemented subjects. A five-fold increase in supplementation corresponded to a five-
fold increase in urinary chromium excretion. Thus, the authors suggest that urinary
chromium excretion might be a useful indicator of intake but not status (Anderson et al.,
1982).
The ·effect of zinc status on chromium uptake was documented in rats by Hahn
and Evans (1975). When rats were given test doses of zinc and chromium, the zinc
deficient rats showed a chromium uptake of five-fold compared to zinc supplemented rats
suggesting that chromium and zinc share a common absorption pathway. Thus, when
rats were zinc deficient, chromium was better absorbed.
Trace Mineral Internctions
This section reviews trace mineral interactions. Interactions of zinc-copper, zinc-
iron, and copper-iron are discussed.
Interaction between Zinc and Copper
The negative effect of excess zinc on copper bioavailbility has been identified as
one of the significant trace element interactions (O'Dell, 1989). Early animal studies
reported that high dietary zinc induced copper deficiency which was reversed by copper
supplementation (Magee and Matrone, 1960).
Boukaiba et ale (1993) found a significant effect of zinc supplementation on serum
copper in institutinalized elderly. In a 16-week crossover study, subjects were
supplemented with 153 umol of zinc for eight weeks and later with placebo for another
eight weeks. After zinc supplementation, serum copper was significantly lower (16.9 ±
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1.10 umol/L) compared to post placebo period (20.3 ± 0.87umol/L). The mean baseline
serum copper concentration of the total group was 21.3 ± 0.64 umol/L, suggesting the
significant decrease in serum copper was due to zinc supplementation.
Therapeutic doses of zinc have been reported to cause copper deficiency in
different age groups. Botash et al., (1992) reported a case study of a thirteen month-old
who was hospitalized with a fever of 4O.8°C. She was anemic with poor weight gain and
abnonnal sparse hair. The mother and the other sibling had a history of Acrodennatitis
Enteropathica and were treated with zinc gluconate. However, this child did not have any
such history. In spite of nonnal baseline serum zinc levels and no clinical signs of
Acrodennatitis Enteropathica, at the age of six months she was given oral zinc gluconate
(16 mg elemental zinc/d) and increased (24 mg of elemental zinc/day) one month prior to
hospitalization. Bone marrow fmdings upon admission suggested copper deficiency.
The subject's plasma zinc concentration was 36.7 umol/L (normal range 9.2 to 19.9
umol/L), serum cerUloplasmin level was 20 mg/L (nonnal range 230 to 580 mg/L), and
serum copper was undetectable (limit of detection was 1.6 umol/L). Copper therapy of
600 ug/day was initiated and continued for 4 days. The patient was discharged and
treated with 600 ug copper chloride per day. Serum zinc decreased to nonnal values after
one year of copper treatment, whereas serum ceruloplasmin and serum copper reached the
normal range within two months of the therapy (Botash et al., 1992).
Several other case studies have also reported a negative influence on copper with
the intake of therapeutic levels of zinc (Prasad et al., 1978; Hoogenraad et al., 1978;
Hoogenraad et al., 1984; Hoffman et al., 1988, Patterson et al., 1985, and Gyroffy and
Chan, 1992). Hoffman 'et al., (1988) described a case study of a thirty-five year old
female patient with a gastric ulcer who received daily doses between 440-660 mg of zinc
(as zinc sulfate) for ten months in addition to a daily multi vitamin-mineral preparation
containing 80 mg of zinc sulfate. Serum zinc concentration more than doubled to 1.44
ug/dL from baseline (0.63 ug/dL) and serum copper concentration decreased to 0.15
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ug/dL from baseline (0.6 ug/dL). Serum ceruloplasmin was not detectable (nonnal 22.9-
43.1 mg/dL). This zinc therapy also increased the excretion of zinc in urine ten times
nonnal (nonnalI5-60 ug/24 hrs). A 10 mg intravenous preparation of cupric chloride
given over a five day period restored ceruloplasmin levels to nonnal concentrations.
Serum ceruloplasmin levels increased to 19.5 mg/dL after two weeks and to 35 mg/dL
after six months of supplementation; however, urinary zinc excretion remained high for
the next three months.
Copper deficiency occurred in a fifty-seven year old man with fatigue and
microcytic anemia who ingested 810 mg of elemental zinc/day for eighteen months.
Serum zinc was more than 3000 ug/L (nonnal550-1400 ug/L), serum ceruloplasmin was
23 mg/dL (nonnal 70-155 mg/dL), and urinary copper was <10 ug/24 hours (nonnalI5-
150 ug/24 hours). After discontinuing the zinc supplements, serum copper and
ceruloplasmin increased to nonnal concentrations; after 8 weeks, serum copper increased
significantly to 134 ug/dL and ceruloplasmin increased significantly to 32 mg/dL.
Anemia and hypocupremia were corrected after discontinuation of zinc (Gyorffy and
Chan, 1992). In another case study of a 57 year old man Patterson et al. (1985), reported
similar changes in copper status after discontinuing zinc supplements. This person also
had symptoms of easy fatigability and anemia. The subject took zinc supplements of 450
mg/d for two years with 2000 ug/d of vitamin B-12 five weeks prior to admission. His
diagnosis was sideroblastic anemia resulting from copper deficiency. Upon admission,
zinc supplements were discontinued. By eighty-three days serum zinc, copper, and
ceruloplasmin concentrations were within nonnal ranges. There was a decrease in serum
zinc concentration to 110 ug/dL (nonna! 50-160 ug/dL); serum copper increased to 104
ug/dL (nonna! 70-90 ug/dL); and ceruloplasmin increased to 37 mg/dL (20-35 mg/dL)
(Patterson et al., 1985).
Samman and Roberts (1988) found gender differences in the effect of zinc on
copper status indicators in young adults. Supplementation with 660 mg of zinc sulfate
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per day for six weeks increased plasma zinc in both males and females. However,
reduced ferroxidase activity, the name proposed for ceruloplasmin, and erythrocyte
superoxide dismutase (E-SOD) antioxidant activity was found in female subjects only. In
a separate study with adult men, Fischer et al., (1984) gave 50 mg of zinc for six weeks
resulting in significant increases in plasma zinc. Plasma copper and serum ferroxidase
activity (ceruloplasmin) were not altered by zinc supplementation, but erythrocyte
superoxide dismutase activity decreased at six weeks in zinc treated subjects but not in
controls. Similar fmdings were reported by Yadrick et al., (1989) in a study using adult
women. Zinc supplementation of 50 mg/day for 10 weeks did not affect serum
ceruloplasmin concentration, but E-SOD levels declined significantly after six and ten
weeks of supplementation. The levels were significantly lower compared to pretreatrnant
levels. Thus, conflicting results have been reported for gender differences in the effect of
zinc supplementation on indicators of copper status.
Festa et al. (1985) also found a negative effect of zinc intake on copper retention
in adult men. Subjects consumed diets containing 2.6 mg of copper/day in addition to
1.8, 4.0, 8.0, 18.5 or 20.7 mg of zinc per day for one or two week periods in a 63-day
study. Copper retention and fecal copper were influenced by the level and duration of
zinc intake. An intake of 18.5 mg of zinc/day for two consecutive weeks resulted in
increased fecal copper and reduced copper retention even with a copper intake of 2.6 mg
daily. This excretion was significantly higher from all the other periods and exceeded
intake, leading to negative copper balance. Copper excretion was not significantly altered
at other tested levels (Festa et al., 1985).
Zinc supplementation (24 mg per day) did not affect serum copper concentrations
in a short tenn study in adult women. Taper et al., (1980), found that supplemental zinc
did not affect serum zinc or copper. They gave either 8, 16 or 24 mg of zinc along with
2 mg of copper for 12-days and found neither an increase in serum zinc concentration nor
a decrease in serum copper concentration. However, all the subjects were in negative
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copper balance as detennined by copper retention and urinary excretion of copper at the
end of the study.
The effect of low dietary zinc on copper status was assessed in a 24 hour
metabolic balance study in young adult females by Colin et ale (1983). Subjects were
given different diets with (18.4-19.9 mg/day) zinc and low (9.5-10.1 mg/day) zinc along
with either a high (nitrogen intake 15.2 g/day) or a moderate protein (nitrogen intake 7.9
g/day) diet with a constant copper intake of 2.0 mg. Dietary zinc did not affect copper
retention or excretion. Plasma copper was reported to be within the nonnal range of 87-
153 ug/100 ml. However, women consuming the high protein -low zinc diets had
higher plasma copper levels at the end of the study than did moderate protein - high zinc
diets, but the difference was not significant. Changes in measures of copper status were
not significant for any treatment group.
The amount of dietary copper may cause changes in copper status in response to
zinc supplementation. Greger et ale (1978a) found different results in two different
metabolic studies. No differences in fecal copper excretion or copper retention occurred
when 7.4 or 13.4 mg of zinc and 2.9 mg of copper/day were fed to 14 adolescent girls
for 18 days. All the subjects were found to be in positive copper balance (Greger et al.,
1978a). However, in a different metabolic study with adolescent girls when dietary
copper was reduced to 1.2 mg/day, they found a significantly higher fecal copper
excretion and reduced copper retention when fed 14.7 compared to 11.5 mg of zinc/day
during lo-day periods (Greger at al., 1978b). The results from the above studies suggest
that dietary copper intake at the lower level of ESADDI inhibited the effect of zinc
supplements on copper status during short tenn metabolic studies.
Negative effects of zinc on copper were reported in studies with a high ratio of
zinc to copper in rats. Van Campen (1966) reported that negative effects of zinc on
copper could be found only with a very high zinc and copper ratio (500: 1). At this high
ratio of Zn:Cu, a significant depression of approximately 60 percent occurred in copper
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uptake from the stomach and duodenum in rats. However, at a ratio of 50:1, copper
absorption was not altered.
Negative effects of zinc on copper have been used to treat diseases like Wilson's
disease (copper toxicity). In two separate case studies, patients with severe neurological
symptoms due to Wilson's disease were corrected by zinc therapy. Subjects were treated
with 300 mg of zinc three times a day. Plasma copper and ceruloplasmin concentration
decreased and plasma zinc concentration increased during the treatment (Hoogenraad et
al., 1984). In another case study of a Wilson's disease patient, Hoogenraad et al. (1978)
examined the influence of oral zinc sulfate. The patient had very high urinary copper
excretion of 350 ug/24 hours (nonnal5-25 ug/24 hours), low serum copper 50 ug/dL
(nonnal (80-140 ug/dL), and.low serum ceruloplasmin concentration of9 mg/dL (nonna!
25-43 mg/dL). The patient was supplemented with 600 mg zinc along with 1.6 mg
dietary copper daily for 3 months. Urinary copper decreased to 100 ug/24 hours, serum
copper to 35 ug/dL, and serum ceruloplasmin to 4.5 mg/dL. The authors suggested that
zinc treatment not only prevented further tissue copper accumulation but also contributed
to the gradual removal of deposited copper. However, serum copper and ceruloplasmin
which were below nonnal ranges before treatment continued to decrease further below
nonnal ranges.
Interaction between Zinc and Iron
Changes in iron metabolism due to excessive zinc may result from both an indirect
multi-element interaction of zinc:copper:iron. A direct antagonistic interaction is found
between zinc and iron (Kirchgessner et al., 1982). Inorganic zinc impairs the intestinal
absorption of iron (Crofton et al., 1989). They conducted an absorption test on healthy
adult males to study the effect of zinc on iron. The study consisted of two parts. The
frrst part was the administration of two test solutions: one had 842 umol of elemental
iron, and the other solution had 344 umol of elemental zinc in addition to the same
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amount of iron. The second part of the study consisted of three solutions with 421 umol
of elemental iron in the frrst solution, 421 umol of zinc along with iron (FefZn 1:1) in the
second solution, and 1048 umol of elemental zinc with iron (Fe{Zn 1:2.5) in the third
solution. Co-administration of zinc did not affect radiolabeled iron absorption at three or
six hours, total plasma iron, or iron retention. In the second part plasma iron declined
significantly when the second solution was given (Fe{Zn 1:1). Plasma iron futther
decreased significantly when the ratio was increased to 1:2.5.
The interaction of zinc and iron in the intestine of healthy human adults was
studied by Solomons and Jacob (1981). The change in plasma zinc concentration after
oral zinc administration was used as the index of zinc absorption. The standard zinc dose
was 110 mg as zinc sulfate dissolved in Coca-Cola and ingested either alone or with non-
heme iron at doses of 25, 50, or 75 mg. These solutions represented FefZn ratios of 1:1,
2:1, and 3:1. In this study a ratio of FefZn of 1:1 slightly inhibited zinc absorption while
FefZn ratios of 2:1 and 3: 1 substantially inhibited zinc uptake. However, when heme
iron (heme chloride) was given at a ratio of 3:1 FefZn and zinc in an i~organic fonn, iron
did not have an effect on plasma zinc. Absorption of the organic fonn of zinc (54 mg
provided by oysters) with or without 100 mg of ferrous iron (FefZn ratio 2: 1) was not
affected by iron. Thus, the results revealed that the competitive interaction of zinc and
iron was strongest between nonheme iron and inorganic zinc.
The effect of inorganic zinc on iron status was measured by Yadrick and co-
workers (1989). Young women were either given 50 mg zinc (zinc gluconate) or 50 mg
of iron (ferrous sulfate monohydrate) in addition to 50 mg of zinc for 10 weeks. In the
group receiving only the zinc supplement, serum ferritin and hematocrit decreased
significantly. In the zinc and iron supplemented group, serum ferritin increased
significantly after 10 weeks of supplementation, but there was no effect on hemoglobin or
hematocrit Thus, the supplemental iron compensated for the loss in storage iron when
zinc alone was given.
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Effects of iron and folic acid on zinc bioavailability were ,studied by Meadows et
al. (1983). They conducted a two week study with pregnant women as a study group
and non-pregnant women as the control group. They found that zinc bioavailability
decreased with intake of oral iron as ferrous fumerate. Zinc bioavailability as estimated
by plasma zinc was evaluated before and after 24 hours of fasting following two weeks
of oral iron supplementation and folic acid in controls. After 12 hours of fasting, subjects
were given 220 mg of zinc sulfate (by mouth) and then oral iron and folic acid
supplements (100 mg iron and 350 ug folic acid) daily for 14 days. The results indicated
decreased zinc bioavailability after iron- and folic acid supplementation as measured by
changes in the plasma zinc curve. The shape of the plasma curves suggested that this was
due to impainnent of intestinal absorption of zinc. However, contrasting results were
obtained when infants were studied. Serum zinc in 12 month old infants was not affected
by thirty milligrams of ferrous sulfate per kilogram body weight given before breakfast
every day for 3 months. However, serum ferritin and iron concentrates were
significantly higher in the iron supplemented group than in the palcebo group. An
increase in hemoglobin was reported in the iron group but not in the placebo group.
Although there was a slight decrease in serum zinc in the iron supplemented group, the
decrease was not significant (Yip et al., 1985).
Pregnant women are commonly supplemented with iron which might affect zinc
status. Iron status was assessed in zinc supplemented pregnant women by Simmer et ale
(1987). Healthy pregnant women were given 25 mg of oral zinc (zinc sulfate) after an
overnight fast Blood samples were collected before and 1, 2, 3, and 4 hours after the
zinc dose. Hemoglobin, total iron binding capacity (TIBC), serum iron and mean
corpuscular volume (MCV) were measured in the fIrst blood sample. Subjects were then
supplemented daily with 100 mg of ferrous iron and 350 ug of folate for two weeks, and
zinc absorption was reassessed 24 hours after the final doses. For comparison, zinc
absorption was also measured in non-pregnant healthy volunteers. After an overnight
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fast, they were given 50 mg of oral zinc. Blood samples were collected and analyzed
similarly to pregnant subjects. These volunteers were also supplemented with 350 ug
oral folate but not iron daily for two weeks, and zinc absorption was reassessed after the
final dose. In the pregnant women, zinc absorption was reduced 24 hours after iron-
folate supplementation suggesting a mucosal rather a luminal effect Also, zinc
absorption was reduced by folate supplements. Therefore, the researchers concluded that
routine iron and folate supplementation may have deleterious effects on zinc metabolism
due to inhibition of iron and folate on zinc absorption.
Research has also shown that zinc can affect measures of iron status. Research
was conducted to investigate iron-zinc interactions in humans under conditions of high
zinc/iron ratios. Hambidge et al. (1983) examined measures of zinc status in pregnant
women either supplemented or unsupplemented with 15 mg Zn/day. These subjects also
received daily iron supplements. Negative correlations between the level of prenatal iron
and plasma zinc and between iron and alkaline phosphatase activity (measure of zinc
status) were reported in these subjects. Furthennore, the non-supplemented group had
higher alkaline phosphatase activity than did the supplemented group (Hambidge et al.,
1983).
Zinc status is affected by the extent of iron supplementation and by its
discontinuation. Newhouse et al. (1993) studied the effects of iron supplementation and
discontinuation on serum zinc in 111 healthy women between the ages of 18 and 40
years. Forty-five subjects were either iron deficient (hemoglobin level below 120 gIL) or
iron deplete (serum ferritin below 20 ugIL) before entering the study. These subjects
were supplemented with 100 mg elemental iron per day for 12 weeks. Serum ferritin
increased significantly from baseline (15.9 ±22.5 ugIL) to the end of the 12 week
supplementation period (36.5 ± 32 ugIL) of 12 weeks and remained significantly higher
than baseline during next 12 week discontinuation period. The treatment did not
significantly affect serum zinc concentrations during the supplementation period.
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However, during the discontinuation phase, there was a decrease in serum zinc
concentrations so that by 18 and 24 weeks the values were significantly lower than
baseline concentrations.
Due to the interaction between iron and zinc, excessive iron levels in a multi-
mineral supplement may negatively affect zinc absorption. Sandstrom et al., (1985)
reported a significant effect of high iron to zinc ratio on the zinc absorption in healthy men
and women between 20-50 years of age. Fasted subjects were given test solutions of 40
umol oral elemental zinc (65Zn) and three other solutions containing additional elemental
iron of 40, 100, and 1000 umol corresponding to 1:1, 2.5:1, and 25:1 ratios of Fe:Zn
respectively. The absorption of zinc was detennined from measures of whole body
retention after 14 days. When given alone, zinc absorption was 74 percent; zinc
absorption decreased significantly to 58 percent at 1:1 FefZn ratio. At a Fe:Zn ratio of
2.5: 1, zinc absorption remained at 58 percent. However at a FefZn ratio of 25:1, zinc
absorption decreased significantly to 34 percent At that same ratio (25:1), the inhibitory
effect of high levels of iron was alleviated by adding histidine (4 mmol), a zinc ligand, to
the water solution (1000 umol of iron). This histidine addition resulted in increased
absorption from 34 to 47 percent. Thus, the intake of a supplement with a meal may
overcome the inhibitory effect of iron. In the same study, a test meal consisting of rice
and meat sauce with an inherent ratio of FefZn of 1:1 resulted in zinc absorption of 25
percent. Addition of ferrous sulfate (100 or 1000 umol) increased FefZn ratios to 2.5:1
and 25:1, but did not significantly change zinc absorption.
Nutritional Assessment
Nutritional assessment evaluates the nutritional status of individuals or





Dietary assessment measures the quantity of individual food consumed for a
certain period of time or the pattern of food consumption. The sensitivity of dietary
assessment instruments to changes in the nutrient intake or dietary behavior under study
should be considered in nutrition-intervention research (Krista! et al., 1994).
Several dietary assessment techniques are used to assess food intake. Of those,
commonly used methods include 24-hour recall, food frequency questionnaires, and food
records. The validity of any method is influenced by the intelligence, motivation, co-
operation of the subject, and also the techniques used by the investigator. In addition,
rapport between the subject and the interviewer is important for collecting complete and
accurate infonnation (Beal, 1967).
. A 24-hour recall is a retrospective method to evaluate food intake over the past 24
hours. The disadvantage of this method is that it may result in inaccurate reporting or
deviation from usual eating pattern (Buzzard, 1994). According to Gersovitz et ale
(1974), decline in short-term memory with age makes this method unreliable to be used in
the studies involving elderly. In their study the elderly subjects (mean age of72 years)
reported mean intakes of each nutrient greater than the mean actual intake; however, this
was significant for protein only.
A food record is a written record of the food eaten and is written at the time of
consumption. Food records vary in length of time for which the infonnation is recorded
However, food records longer than 3 days may not provide valid infonnation on intake.
Validity of the seven-day food record was investigated among non-institutionalized
elderly who were participating in a congregate meal program. Records collected during
the first few days provided more accurate estimates of the mean intake compared to fifth,
sixth, and seventh days (Gersovitz et al., 1978). In a study using adolescents,
Mullenbach et ale (1992) found that 3-day food records provided accurate estimates of
dietary intake compared to 24-hour dietary recall.
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Different methods of dietary assessment to obtain infonnation on the quality of
diets have been reviewed by Medlin and Skinner (1988). This review described
individual assessment methods and their evolution over 50 years. The authors suggested
that knowledge of the strengths and limitations of current dietary assessment
methodology is essential for researchers and practitioners in order to select appropriate
methodology and to interpret the findings. The review recognized that various methods
yield different results. The intakes may be underestimated or overestimated consistently
with the method used.
Accurate food intake estimates can be achieved by using food models and with
prior notification of subjects. Posner et ale (1992) conducted validity research on two-
dimensional food models used to estimate portion sizes in nutrition research. They used
the 24-hour recall method to evaluate the intake. Pearson correlation coefficients between
the two- and three-dimensional methods were high. This research supported the use of
food models to estimate serving sizes in nutrition research.
It was reported that using graduated food models reduced time needed for
interviews and also decreased the frustration of the respondents. This also reduced the
individual variation in estimating the food intake and led to more accurate estimates. In
addition, models helped in easy handling of the data since the answers were "definite,
comparable, and consistent" (Moore et a!., 1967).
Despite the method used, the accuracy of the calculated estimates depends on the
degree of food description detail. In addition, quantification coding and calculation
procedures that are used to convert the food intake data into nutrient intakes also affect the
accuracy of the data (Buzzard, 1994).
AnthrQPOmetric Assessment
Anthropometric measurements frequently used in clinical settings and nutrition
surveys include weight, height, skinfold thickness, and bioelectrical impedance to
,::Jl
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estimate percentage of body fat and lean body tissue in the body. It was reported that
anthropometric measurements in the elderly vary with age, sex, health practices, and the
presence of certain disorders like diabetes and hypertension (Kubena et al., 1991).
Kubena et ale (1991) studied the relationship between anthropometric measurements and
health behaviors and disorders in elderly non-institutionalized Caucasians. Their results
showed differences in anthropometric indexes due to age and sex.
Master and Lasser (1960) presented height and weight standards for persons aged
65-94 years. The mean height range of men was reported to be 154-185 cm with an
average weight of 72 kilograms. Whereas, women were reported to have a mean height
range of 147-175 cm with the average weight being 64 kilograms. In both the sexes, the
average weight decreased with advancing age. In a later study, Roubenoff and Wilson
(1993) reported that the stature often decreases with age.
With accurate height and weight measures, body mass index can be computed for
individuals. It is calculated as weight (kg)/height (m)2 (Deurenburg et al, 1988). Body
mass index is correlated with body fat in young adults; however, it might lead to
inaccurate estimates of body fat in older adults due to decreased height, increased body
fat, and decreased lean body tissue. Burr and Phillips (1984) reported a decline in body
mass index in elderly with advancing age. This could be due to a change in individual's
height and weight of the individuals as they grow older since the BMI is adjusted for
height and weight.
Bioelectrical impedance analysis (BIA) is a widely used method which gives
reliable and valid assessment of body composition (Lukaski, 1987). The principle of this
method is that the resistance of an electric current is proportional to the amount of fat free
mass. Body composition changes with advancing age leading to a decrease in fat free
mass, consequently increasing fat mass (Novak, 1972; Noppa et al., 1979). Novak
(1972) conducted a study on adult men and women volunteers aged 18 to 85 years. The
purpose of the study was to detennine the relationship between fat free mass and age in
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both males and females. The results indicated that fat content was double in the oldest
group (65-85 years) compared to the youngest group (18-25 years). A steady increase in
percentage fat was reported with a decrease in fat free mass in both the sexes. Noppa et
ale (1979) also reported similar changes in body fat mass with advancing age.
Bioelectrical impedance analysis is reported to be a valid method in predicting lean body
mass in large heterogeneous population (Segal et al., 1988). Bioelectrical impedance
analysis is a valid method of predicting fat free mass and fat mass in elderly when age-





Thirty four volunteers over 55 years of age participated in the study. The subjects
were recruited by contacting local physicians, organizations and by mailing a letter to all
the staff and faculty of Oklahoma State University (Appendix A). These volunteers
reported that they were free from chronic illness, non-users of medication, and were
maintaining current body weight. After explaining the study, an infonned consent was
obtained from each subject (Appendix B). The experimental protocol was approved by
the Institutional Review Board of Oklahoma State University (Appendix C).
Supplement Preparation
The zinc, copper and chromium supplements were prepared in the nutritional
sciences laboratory using a gelatin capsule filling machine (Quanterron, Inc., Minnesota).
Zinc supplements were prepared by mixing 64.8415 grams of zinc sulfate
(ZnSO4.7~O) and 349.7674 grams of lactose in a ball mill for 8 hours. The gelatin
capsules were filled with the mixture calculated to contain 15 mg of zinc per capsule.
Similarly, 7.2551 grams of copper carbonate [Cu2(C03)3] in 708.7449 grams of lactose,
and 1.2587 gms of chromium chloride (CrCI3.6H20) in 427.1798 gms of lactose were
mixed to make the capsules to contain 1.5 mg of copper or 100 ug of chromium in each.
Number two clear gelatin capsules (Item # 16014, Apothecary Products, Inc., Burnsville,
MN) were used to make the supplements. Sample capsules were wet and dry ashed
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using a modification of the Hill et al.(1986) method and tested for mineral concentration
using the atomic absorption spectrophotometer (Model 5100 PC; Perkin-Elmer Corp.,
Norwalk, Cf). The average analyzed chromium, copper and zinc contents of the
supplements were 120.66 ug, 1.692 mg and 15.18 mg, respectively.
Experimental Design
This study was a randomized design with time as a repeated measure. The
subjects were randomly assigned to one of four supplement groups (placebo, chromium,
copper, or zinc) such that the proportion of males and females in each group was similar.
Subjects consumed the supplements or placebo for eight weeks beginning
immediately after baseline data collection. Subjects were instructed to consume one
capsule in the morning and one in the evening with meals. Subjects received one month's
supply of supplements and were asked to return the container at the following collection
period for detennination of actual supplement consumption. In addition to taking the
supplement, subjects were advised to maintain usual diets and exercise patterns during the
course of the study.
Data were collected four times during the study: baseline, at four and eight weeks
of supplementation and four weeks post supplementation. Twelve hour fasting blood
samples and routine anthropometric measurements were collected at each data collection
period. Prior to each measurement period, subjects recorded a 3-day food intake.
Procedures
Health Infonnation Questionnaire
Prior to the baseline measurement, each subject completed a health profile
questionnaire. Infonnation pertaining to the subject's past medical history, type of
special diet, current medication, dietary supplements used in the past six months, recent
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serious illnesses or surgery, serum cholesterol concentrations, exercise, and family
history of elevated cholesterol or heart disease was collected (Appendix D).
Monthly pata Collection FOOD
Each subject completed a monthly data collection fonn at each of the four
measurement periods. The monthly data collection fonn was designed to detect recent
illnesses which might affect biochemical measures. In addition, maintenance of exercise
pattern was detennined at this time (Appendix E).
DietarY Intake Data
Subjects were given verbal and written instructions by a Registered Dietitian for
recording food intake. A set of non-biasing food models were provided to each subject
during the study. The food models were prepared in the laboratory using a modification
of the method of Moore et al., (1967). Colored nylon net with a measured volume of
dried beans were used. Different colored nylon was used to code for different amounts.
A red nylon net circle of 10 and 1/8 inches in diameter was used for the one cup
measurement Yellow circular nylon net seven and a half inches in diameter was used for
a half cup measure, and a blue nylon net circle six and a half inches in diameter was used
for a one-third cup measure. A double layer of nylon net was sewn together on the edges
and were filled with the corresponding volume of dried pinto beans. The thread was
pulled together to close the bag and was knotted. A three-dimensional wooden block
with the dimensions of length: 3 1/8 inches, breadth: 2 1/8 inches, and height: 0.75
inches was used to represent 3 oz of meat
Three-day dietary records were kept by the subjects before the supplementation, at
four weeks, eight weeks and four weeks post supplementation. The three-day dietary
records included only the week days (Appendix F). The Food Processor Plus, version
5.03 (ESHA Research, Salem, OR) was used to analyze the reported intakes. This
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program does not have values for chromium. Missing data are indicated by blanks.
Additional foods were included in the database from food label infonnation, restaurant
menus and home recipes. Infonnation about the supplements was included as a data file.
Anthropometric Data
Subject's standing height was measured at the baseline and at the 8 weeks
supplementation periods. With the subject standing erect against the wall with barefoot
heels together, a scaled rule attached to the wall was read to the nearest 1/4 inch.
Subjects' body weight was measured' at four measurement periods using a calibrated
body weight scale (Continental Co., Chicago). Accuracy was read to the nearest one
quarter pound increment.
KneeHei~ht
Often stature decreases with age (Roubenoff and Wilson, 1993). Knee height
measurement is used to estimate stature of adults 60 to 90 years. It can also be used with
other anthropometric measures to predict weight. It is a reliable estimate of stature when
used to adjust body composition measurements included in bioelectric impedance.
Knee height was measured during the second data collection period using a Ross
Knee Height Caliper (1989) (Ross Laboratories, Columbus, OH). Measurements were
done in duplicate and averaged to ensure accuracy of measurements within 0.5 cm.
Subjects were reclined in a supine position with the left knee and left ankle bent at 90
degree angles to take the measurement. The caliper was held with a locking mechanism
and read to the nearest 0.1 cm through the viewing window. Equations to estimate knee
height were provided by Ross Laboratories. The equations are specific for age and
gender. Stature for men is calculated from knee height by the following equation:
[2.03 x knee height (cm)]-[O.04 x age (yr)] + 64.19.
Stature for women is calculated from knee height by the following equation:
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[1.83 x knee height (cm)]-[0.24 x age (yr)] + 84.8.
Bioelectrical Impedance
Bioelectrical impedance is dependant on body water. Hydration can be affected
by intake of alcohol, diuretics or caffeine, recent exercise or food intake, and abnormal
body temperature. Bioelectrical impedance was used as a noninvasive and simple method
to measure body composition. Bioelectrical impedance measures battery-charged
electrical conductivity of fat-free tissue using whole body reactance and resistance to
estimate lean body mass and total body fat (Biodynamics Model 310, Body Composition
Analyzer, Chattanooga Corporation, Chattanooga, TN).
Subjects were measured during the frrst and third data collection period by a
trained research assistant. The test was performed after a 12-hour fast, and the subjects
were assumed to be adequately hydrated. All the jewelry was removed before the
measurement. Each subjects was instructed to lay on a horizontal surface in a supine
position~ The subject was positioned with hands, palms down, at least six inches apart
from the body. The feet were also positioned six inches apart. The right ann and leg
were exposed for the placing the electrodes. Each subject was instructed to place the
hand in the dorsiflexion position and an electrode was placed near the subject's wrist at
the point where the wrist creased Each subject was told to relax the wrist, and the
second electrode was placed on the same hand near the knuckles. Similarly, one
electrode was placed on the subject's right foot near ankle at the point where it creased.
The subject was asked to relax the foot, and the second electrode was placed on the same
foot near the outer toes. The subject was told to relax and to remain motionless for the
duration of the test lasting about 10 seconds. The test was repeated using a new set of
electrodes, and the two values were averaged for analysis. The test was not performed
on the subjects with a pacemaker. The test was perfonned according to the procedure
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described in the User Guide. Subjects' height and weight along with age and gender
were programmed into the bioelectric impedance analyzer.
Blood Collection
At each data collection period between 7:30 and 9:30 am thirty milliliters fasting
blood was collected from the subjects. The blood was collected by a phlebotomist using
a 21 gauge stainless steel butterfly needle and luer-monovette syringes (Starstedt,
W.Gennany). Twenty milliliters of blood was collected in 10 ml neutral tubes which had
been treated with 100 ul of 300 gIL sodium citrate as the anticoagulant. In addition, ten
milliliters of blood were collected in serum luer-monovette tubes. The plasma tubes were
placed on the rotator for mixing until separation, and serum tubes were allowed to clot in
an ice chest. The plasma was separated within 30 minutes of blood collection. The
serum tubes were allowed to clot on ice for two hours before separation.
Plasma and Serum Separation
After transferring one ml of whole blood to a microcentifuge tube for total
hemoglobin analysis, plasma was separated by centrifugation at 3000 rpm for 25 minutes
at four degrees centigrade. Two and a half milliliters of plasma were transferred using a
plastic transfer pipette into a mineral free Falcon tube (Becton Dickinson Labware, New
Jersey)for mineral analysis. Plasma was separated and stored in different microcentrifuge
tubes for analysis of cholesterol, glucose, apolipoprotein A-I, and apolipoprotein B. The
remaining plasma was stored in a second Falcon tube and frozen.
The serum tube was allowed to stand on ice for 2 hours and then centrifuged at
3000 rpm for 55 minutes at 4 degrees centigrade. The clear top layer of the serum was
carefully separated with a plastic transfer pipette and stored in siliconized tubes and frozen
for the analysis of estradiol, insulin, vitamin D, and osteocalcin. Serum was also stored
in a clear microcentrifuge tubes for ferritin analyses. Fresh serum was transferred into a
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microcentrifuge tube for immediate analysis of alkaline phosphatase and then frozen for
subsequent albumin analysis. The remaining serum was stored in a Falcon tube and
frozen.
Preparation of Solutions
Glass distilled deionized water was used to prepare all the solutions. The water
was pretreated in Barnstead filters prior to glass distillation. The same batch of water was
used to make all of the solutions. Glass distilled water was frozen in acid washed plastic
bottles to use for lysing red cells so that all cells would be lysed with the same batch of
distilled water. Fresh bottles were thawed for each data collection period.
Phosphate buffered saline (PBS) was prepared by mixing 7.1 g of sodium
chloride, 1.15 g of sodium phosphate-dibasic salt (N~ HPO4)' potassium phosphate-
monobasic (K H2PO4)' and 0.2 g of potassium chloride in distilled water made up to one
liter. The solution was prepared and the pH was adjusted to 7.2. Six liters of PBS were
prepared at a time, mixed and portioned for using throughout the study.
The anticoagulant was prepared using trisodium citrate and normal saline. Fifteen
grams of trisodium citrate were added to saline and diluted to a final volume of 50 mI.
This solution was mixed thoroughly to prepare 30 percent trisodium citrate. Saline was
prepared by mixing 0.45 g of sodium chloride in 50 ml of distilled water.
washin~ of Red Cells
Mter removing the plasma, the buffy coat was removed carefully by a transfer
pipette. To the remaining red cells, 5 ml of cold phosphate buffer saline (PBS) was
added to suspend erythrocytes. The suspended cells were transferred to a mineral free
polyethylene tube and another 5 ml of PBS was added to the plasma syringe and gently
rinsed to resuspend remaining cells. The tubes with red cells and a total of 10 ml of PBS
solution were closed with parafilm, mixed, and then centrifuged at 3000 rpm for 25
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minutes at four degrees centigrade. The clear PBS solution was carefully drawn off by a
transfer pipette and discarded. Erythrocytes were resuspended as before. The cells were
washed a total of three times. After the final centrifugation, one ml of red cells was
removed and added to a Falcon tube containing 2 ml of distilled water and vortexed
thoroughly to lyse the red cells (RBC). A lysed RBC sample was removed to a
microcentrifuge tube for red cell hemoglobin analysis. The remaining lysed cells were
frozen for mineral analyses. The remaining packed red cells were frozen in capped and
parafilmed falcon tubes and stored.
Biochemical Analyses
Modifications from the manufaturer's methods used in this study are included in
Appendix G. Otherwise, the methods used were as described in the published
procedures.
Total Hemo~lobin
Total hemoglobin was measured by the cyanmethemoglobin method for
quantitative, colorimetric detennination in whole blood at 540 nm using the visible lamp
(procedure # 525, Sigma Diagnostics, St.Louis, MO). In this technique total hemoglobin
at alkaline pH is rapidly converted to the cyano derivative which is detennined by its
absorbance. The color intensity at 540 nm is proportional to total hemoglobin
concentration.
Four cyanmethemoglobin standards (0, 6, 12, and 18 g/dl) were used, and were
prepared in advance and stored refrigerated in plastic bottles covered with an aluminium
foil to protect from light. The standards were stable for 6 months. The same standards
were used for all the samples. Whole blood samples were vortexed thoroughly before
analysis. The procedure was modified by decreasing the amount of blood used for the
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analyses (10 uL), and the amount of Drabkin's solution used (2.5 mL) in order to reduce
hazardous waste.
Serum Albumin
Albumin was measured by the bromocresol purple method specific for human
serum albumin. This is a quantitative, colorimetric detennination in serum at 600 nm
(procedure # 626, Sigma Diagnostics, St.Louis, MO). Human serum albumin reacts
with bromocresol purple (Bep) to fonn a stable blue-purple color complex with
maximum absorption at 600 nm. To five standards, blank and frozen sample duplicates,
1.0 ml of albumin reagent (BCP) was added. To the standard, test and blank, 0.01 mlof
albumin standard (Sigma catalog # 540-10),0.01 ml serum and 0.01 ml 0.85 % saline
was added respectively. The contents were vortexed. The absorbance of standard and
test was read against a blank as reference at 600 nm. The intensity of the color is
proportional to the serum albumin concentration.
Alkaline Phosphatase
Alkaline phosphatase activity in serum was detennined by quantitative, kinetic
detennination using an alkaline phosphatase (ALP) reagent at 405 nm (procedure # 245,
Sigma Diagnostics, StLouis, MO). Serum ALP hydrolyzes p-nitrophenol phosphate to
p-nitrophenol and inorganic phosphate. The hydrolysis occurs at alkaline pH. The p-
nitrophenol fonned shows an absorbance maximum at 405 nm and is directly
proportional to ALP activity of the sample.
The reagents were prepared the day before the analysis. Distilled water was used
as a reference and samples were read in duplicates. Twenty microliters of fresh sample
was used for each analysis.
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Serum Ferritin
Serum ferritin was measured by a double antibody radioimmumoassay method
(Diagnostic Products Corporation, Los Angeles, CA) which quantitatively measures
serum ferritin. Frozen samples (100 uUtest) were brought to room temperature. All the
samples and standards were run in duplicate. Non-specific binding (NSB) tubes were
run in quadruplicate. In this procedure, 125I-labeled ferritin competes with ferritin in the
sample for sites of ferritin-specific antibody. After incubation for a fIXed time, separation
of bound ferritin from free is achieved. The supernatent solution was decanted and the
precipitant was retained and counted for one minute using a gamma counter (Packard
Cobra II, Auto Gamma, Packard Instrument Co., Meriden, eT). The counts are
inversely related to the amount of ferritin present in the sample.
Plasma Minerals
Plasma minerals (zinc, copper, iron, and manganese) were analyzed by atomic
atomic spectrophotometry (AAS). Plasma zinc and iron were read using an air-acetylene
flame, and copper and manganese were read in the graphite furnace.
Plasma was wet and dry ashed by a modification of the Hill et ale (1986) method
and tested for mineral using conentrations using an atomic absorption spectrophotometer,
Model 5100 PC (Perkin-Elmer Corp., Norwalk, Cf). The detailed procedure for ashing
(wet and dry) and dilutions are included in Appendix H.
Statistical Analyses
Data were analyzed using the Statistical Statistical Analysis System (SAS)
program available at Oklahoma State University Computer Center. The General Linear
Model (GLM) was used to detennine significant differences for unbalanced groups.
Comparision of treatment groups to placebo was perfonned by Dunnett's test.





The sample for this study consisted of thirty volunteers over the age of 55 years.
The volunteers were independently living elderly adults in the community of Stillwater,
Oklahoma. The original sample consisted of thirty-four subjects. Four of these subjects
despite their participation in the study were not included in the analyses. Data from male
subjects of the chromium group were not analyzed. Two of these male subjects had high
initial serum ferritin concentrations of 752 and 438 ng/ml. The third subject did not the fit
the specified age range. In addition, data of one male from the placebo group was also
dropped because of an elevated initial serum ferritin concentration of 377 ng/ml. The data
of the only male left in the chromium group were not included in the analyses.
Subject Description by Gender
The sample consisted of thirteen males and seventeen females. Table 1 includes
the baseline anthropometric measures by supplement groups. One female each in the
placebo group and in the chromium group, and one male in the zinc group missed the




Tabl, 1. Means of anthrQRometric measures at baseline by rende,.a,b
Variablec Placebo Chromium Copper Zinc
Males
n 4 - 4 4
Age, yr 56±4* - 62±4* 63±4
Ht, m 1.81 + 0.02* - 1.78 ± 0.02* 1.76 ± 0.02*
Wt, kg * 80.4 + 6.8 83.1 + 6.880.9 ± 6.8 -
OMI, wt/btl 24.7 + 2.1 - 25.5 ± 2.1 24.7 + 2.1
% body fat 22.4 ± 2.6* * 22.3 + 2.1- 24.4 ± 2.6
Females
n 3 6 4 4
Age, yr 72±4·* 58±3 74±4** 64±4
Ht, m 1.62 ± 0.03** 1.59 ± 02 1.58 ± 0.02** 1.60 ± 0.02**
Wt, kg 70.5 + 7.9** 66.7 ± 5.6 61.2 + 6.8 57.4 + 6.8
OMI, wt/htl 26.3 + 2.5 26.2 ± 1.7 24.6 + 2.1 22.3 + 2.1
% body fat >. 35.5 + 3.1** 37.8 ± 2.4 39.9 ± 3.1** 33.2 + 2.6
a. LS Means ± SEM.
b. Variables by sex in columns with different superscripts (*) are statistically significant (p ~ 0.05).
c. Ht = Height, Wt = Weight, BMI = Body Mass Index.
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Anthropometric Measurements at Baseline
By Gender. Mean age, height, body weight, body mass index, and percent body
fat of the subjects according to gender are presented in Table 1. The mean age of females
was significantly higher than males in both placebo and copper groups. However, there
were no significant differences in age between males and females in zinc group. Males of
all the four groups had significantly greater height compared to females. In the placebo
group males were significantly heavier (80.9 ±6.8 kg) than females (70.5 ±7.9 kg).
Weight did not differ significantly between males and females in copper and zinc groups
(Table 1). There was no significant difference between males and females for the body
mass index between groups. However, females in the placebo and the copper groups had
significantly higher percentage body fat compared to males.
By Supplement Group. No significant differences were found among males of
different supplement groups for age, height, weight, body mass index, and percentage
body fat. Similarly, there were no significant differences in age, height, weight, body
mass index, and percentage body fat among females of different groups. Thus, the
sample was homogeneous by gender in supplement groups in relation to anthropometric
measurements at baseline.
Biochemical Measurements at Baseline
By Gender
Baseline means of hemoglobin, serum ferritin, albumin, alkaline phosphatase,
and plasma minerals are reported in
Table 2. The mean initial values for hemoglobin, serum ferritin, albumin, alkaline
phosphatase, plasma zinc, and plasma iron were within nonnal ranges. However,
subjects had lower than nonnal concentrations of plasma copper concentrations.
Males in the copper group had significantly higher hemoglobin concentration




Table 2. Means of biochemical measurements at baseline by render 1,2,3


























































































1. LS Means ± SEM.
2. Rows with different alphabetic superscripts are statistically significant (p 5. 0.05).
3. Variables by sex in columns with different superscripts (.) are statistically signifiant (p < 0.05).
4. Young DS: Implementation of SI units for clinical laboratory data. Ann Int Med 1987;106:114-29.
S. Alk Phos = Alkaline Phosphatase.
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was not found in the other groups. Significant differences for serum ferritin
concentrations were found between males and females in copper and zinc groups. Males
had significantly higher values than females (Table 2). However, there was no
significant difference in the placebo group between males and females for serum ferritin
concentrations.
No significant differences were found in serum albumin and alkaline phosphatase
concentrations between males and females of all the groups. Similarly, no differences
were found in plasma zinc, plasma copper, and plasma iron in any of the groups at
baseline.
By supplement ~oup
There were no significant differences between the supplement groups in
hemoglobin, serum ferritin, albumin, alkaline phosphatase, plasma copper, and plasma
iron concentrations in males. However, the placebo group had significantly higher initial
plasma zinc concentrations in males (12.2 ±0.8 umo1!L) compared to the copper (11.9 ±
0.6 umo1!L) and zinc groups (11.0 ± 0.5 umo1!L) (Table 2).
No significant differences were found in females for hemoglobin, albumin,
alkaline phosphatase, and plasma minerals between the groups. However, females of the
placebo group had significant higher initial serum ferritin concentrations compared to
females of chromium, copper, and zinc groups (Table 2).
Dietary Intake at Baseline
Whole Sample
For the whole sample, 96.7 percent reported protein intakes above the two-thirds
of the Recommended Dietary Allowances (RDA). The frequency distributions for intakes
of selected vitamins and minerals are presented in Figures 1 and 2. Only 56.6 percent of
subjects met two-thirds or more of the RDA for zinc, and 20 percent of the subjects had
• 66.7%-100% RDAlLower Limit of ESADDI
• 50%-66.69% RDA/Lower Limit of ESADDI
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Fig. 2. Frequency distribution o/mineral intake at baseline.




zinc intakes of less than 50 percent of the RDA. Mean intakes of less than two-thirds of
the recommended intake for zinc were previously reported by other researchers in elderly
subjects (Howarth, 1989; Hutton and Hayes-Davis, 1983). Hutton and Hayes-Davis
(1983) studied elderly individuals living in government housing complexes. The mean
total intake of the subjects was 7 mg which was less than 50 percent of the recommended
intake for this age group. This could be due to the fact that their mean food energy was
less than recommended; however, their protein intakes were equal to or exceeded the
RnA. In our study, almost all the subjects had two-thirds or more of the recommended
intakes for protein; however, zinc intakes of less than two-thirds of RDA in 43.4 percent
of our subjects could be due to the quality of foods they selected. National studies
reported a mean intake of eighty-nine percent of RDA for zinc in adult males (Harland et
aI., 1981). Their study was based on the data collected during 1974 and 1975, and the
subjects consumed diets containing a mean energy level of 2,800 kcal. These findings
showed that zinc intake was dependent upon energy level of the diet. The lower intakes
of zinc in males in our copper and zinc groups compared to the placebo group could be
due to corresponding calorie intakes in these groups which were significantly lower than
in the placebo group.
While seventy-three percent of the subjects consumed above two-thirds of the
lower limit of the Estimated Safe and Adequate Daily Dietary Intake (ESADDI) for
copper, only 20 percent of the subjects met 100 percent of the lower limit of the
recommended intake for copper. Furthermore, 10 percent reported consumption of less
than 50 percent of the recommended intake for this nutrient (Figure 2). National studies
have reported intakes less than the recommended levels for copper in both males and
females aged 60-65 years. In the Total Diet Study, intakes of men and women were 1.18
and 0.86 mg per day respectively. These intakes were compared to the recommended
intakes of 1989 (Pennington and Young, 1991). However, our subjects reported
consumption of greater amounts than reported by Pennington and Young (1991). Males
, .
58
and females of OUT study consumed an average of 1.36 (90 percent of the lower limit) and
1.17 mg (78 percent of the lower limit) per day, respectively. In OUT study all the
subjects consumed two-thirds or more of the recommended intakes for iron. Pennington
and Young (1991) also reported an increased intake of iron in elderly. Their study
showed that elderly males and females consumed iron exceeding their RDA at 151 and
106 percent respectively.
By Su~~lementGrou~ and Gender
Placebo. The placebo group consumed adequate amounts of nutrients at baseline. Mean
intakes of both males and females met two-thirds or more of the recommended intakes for
all the nutrients.
Chromium. Eighty-three percent of the females in the chromium group met two-thirds or
more of the recommended intakes for protein and folic acid. All the females of this group
met two-thirds of the recommended intakes for iron and manganese. Thirty-three percent
of the females in the chromium group consumed less than 50 percent of the recommended
intakes for copper, and zinc. Only one female in the chromium group met 100 percent of
the lower limit of ESADDI for copper and 100 percent of the RDA for zinc.
Ccwper. In the copper supplemented group, all the males met two-thirds or more of the
recommended intake for protein, riboflavin, magnesium, iron, and manganese.
However, 25 percent of males in this group reported consumption of less than 50 percent
of the recommended intakes for zinc, and none of them met 100 percent of the RDA for
zinc. The females of the same group met two-thirds or more of the recommended intakes
for protein, vitamins A and C, and all B vitamins. Seventy-five percent of the females
met two-thirds or more of the recommended intakes for zinc, and copper. Similar to the
chromium group, only one female met 100 percent of the recommended lower limit of









~. In the zinc group, all of the males met two-thirds or more of the recommended
intakes for protein, vitamins A and C, and all B vitamins. However, only 25 percent of
the males met two-thirds or more of the recommendation for zinc. Seventy-five percent
of them met the two-thirds or more of the recommended intake for manganese and
copper. None of the males in the zinc group met 100 percent of the RDA for zinc and
only one male in this group met 100 percent of the lower limit of the ESADDI for copper.
All the females in the zinc group met two-thirds of the recommended intakes for protein,
vitamin A, thiamin, riboflavin, niacin, folate, iron, and copper. Seventy-five percent of
the females met the two-thirds or more recommended intakes for vitamin C, B6, B12,
magnesium, and manganese. However, only 25 percent of the females met this
recommendation for zinc. None of the females in the zinc group met 100 percent of
lower limit of ESADDI for copper or 100 percent RDA for zinc.
Overall, the reported nutrient intakes of the sample were good except for copper and zinc.
A majority of the subjects did not meet 100 percent of the RDA for zinc or 100 percent of
the lower limit of the ESADDI for copper. Few subjects consumed less than 50 percent
of the recommended intakes for zinc and copper. However, these subjects met 100
percent of the recommended intake for iron.
Differences in Nutrient Intakes Between Groups by Gender
Mm. The mean nutrient intakes and percent RDAIlower limit of ESADDI at baseline for
males is reported in Table 3. The mean calorie and protein intake of the placebo group
was significantly higher than that of the copper group. The placebo group reported
consumption of significantly greater amounts of riboflavin and niacin compared to the
copper and zinc supplemented groups. Thiamin intake of the placebo group was
significantly greater compared to copper and zinc groups. In addition, copper group
consumed greater amounts than zinc group. Zinc, manganese, and magnesium intakes of
the placebo group were significantly greater than reported in the copper and zinc
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Table 3. Mean nutrient intake of males at baseline 1,2,3
Nutrient Placebo Copper Zinc
n 4 4 4
Energy, Kcal 2214 ±.497a 1514 ±. 86b 1647 ±. 363a,b
Protein, g 105.2 ±. 28a 63.4 ±.10b 78.4 ± lOa,b
(168 ± 57) (98 ± 10) (119 ± 23)
Vit A, RE 1536 ±. 648 795 ±. 397 877 ±. 120
(154 ± 65) (79 ± 40) (88 ± 12)
Thiamin, mg 2.24 ± 0.38a 1.42 ± 0.37b 1.38 ± 0.14b, c
(187 ± 32) (118 ± 31) (115 ± 12)
Riboflavin, mg 2.20 ± 0.36a 1.40 ± 0.26b 1.86 ± 0.17b
(157 ± 25) (100 ± 18) (133 ± 12)
Ni3cin, mg 31.05 ±. 6.43 18.3 ± 2.4b 23.5 ± 1.5b
(207 ± 42) (122 ± 16) (157 ± 10)
B 6, mg 2.88 ±. 0.56a 1.32 ± 0.53b 1.89 ± 0.26b
(144 ± 29) (66 ± 27) (95 ± 13)
B 12, ug 8.54 ± 2.93 4.1 ± 2.20b 3.81 ± l.72b
(427 ± 145) (205 ± 110) (191 ± 86)
Fol3te, ug 306 ± 18 226 ±. 93 277 ± 61
(153 ± 9) (113 ± 46) (138 ± 30)
Vit C, mg 185 ±833 78 ± 62b 129 ± 523,b
(309 ± 138) (129 ± 104) (215 ± 87)
Vit D, ug 8.59 ±. 6.72 5.77 ± 3.85 4.98 ± 4.24
(172± 134) (115 ± 77) (100 ± 85)
Calcium, g 949 ±. 3453 548 ± 207b 941 ± 1423
(119 ± 43) (79 ± 19) (118 ± 18)
Copper, mg 1.77 ±. 0.353 0.98 ± 0.23b 1.33 ± 0.383,b
(118 ± 24) (65 ± 15) (89 ± 25)
Iron, mg 17.5 ±. 4.2 13.2 ±. 2.7 13.8 ±. 4.2
(175 ± 42) (132 ± 27) (138 ± 45)
Mg, mg 423 ±. 843 244 ±24b 312 ± 59b
(121 ± 24) (70 ± 7) (89 ± 17)
Mn,mg 4.77 ±. 2.293 2.21 ± 0.52b 2.28 ± 1.16b
(239 ± 115) (111 ± 26) (114 ± 58)
Zinc, mg 15.0 ± 2.23 8.95 ± 2.32b 9.55 ± 3.01b
(100 ± 15) (60 ± 15) (64 ± 20)
1. LS Means ± SEM.
2. Figures in parenthesis are percent RDAllower limit of ESADDI.
3. Values in a row with different superscripts are significantly different (p ~ 0.05).
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supplemented groups as were the intakes of B6 and B12. The placebo group reported
greater intakes of calcium and copper than the copper group but not greater than the zinc
group. However, there were no significant differences in the nutrient intakes among
males of the different groups for vitamin A, D, folate and iron. The intake of iron in the
placebo group was higher compared to copper and zinc groups, but this difference was
not statistically significant
Females. The mean nutrient intakes of females of all the groups at baseline are
presented in Table 4. For most nutrients no significant differences were found among
females of the different groups (Table 4). The placebo group consumed significantly
greater amounts of thiamin, niacin, and magnesium compared to the zinc supplemented
group. Riboflavin intake was significantly higher in the placebo compared to chromium
and zinc groups but not different from the copper group. However, intake of riboflavin
of the copper group was significantly greater than the zinc group. Intake of iron was also
found to be significantly greater in the placebo group compared the zinc group. There
were no significant differences in the intake of copper or zinc between the groups (Table
4).
Chan~esOver Time by Gender
Placebo. In males at eight weeks of supplementation (M3) protein intake was
significantly less than baseline consumption in placebo group. A significant decrease in
intakes of copper and zinc was also found from baseline to four weeks post
supplementation (M4) in this group. However, females in the placebo group reported a
significant increase in copper intake from baseline to four weeks of supplementation
(M2).
Chromium. Females in the chromium group reported consistent intakes throughout the
study. There were no significant changes in the nutrient intakes over time.
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Table 4, Mean nutrient intake Qf females at baseline 1,2,3
Nutrient Placebo Chromium Copper Zinc
n 3 6 4 4
Energy, Kcal 1906 ±. 455 1527 ±. 713 1540 ±. 273 1389 ±. 196
Protein, g 74,7 ±. 17,7 66.4 ±. 30.0 56.5 ±. 4.8 54.5 ±.12.5
(139 ± 40) (122 ± 30) (117 ± 12) (120 ± 30)
Vit A, RE 1577 ±. 205 1266 ±. 609 1305 ±. 656 1121 ±. 620
(197 ± 26) (153 ± 76) (163 ± 82) (140 ± 78)
Thiamin, mg 1.55 ±. 0.49a 1.25 ±. 0.41a,b 1.46 ±. 0.30a,b 0.99 ±. 0.17b
(155 ± 49) (125 ± 41) (146 ± 30) (99 ± 17)
Riboflavin, mg 2.16 ±. 0.54a 1.52 ±. 0.43c 1.89 ±. 0.16c 1.17 ±. O.13b
(180 ± 45) (126 ± 36) (157 ±13) (98 ± 11)
Niacin, mg 2.51 ±. 4.9a 18.8 ±. 7.sa ,b 18.8 ±. 2.8a,b 15.5 ±. O.60b
(193 ± 37) (144 ± 58) (145 ± 22) (119 ± 34)
B6, mg 2.27 ±. 0.43 1.85 ±. 0.62 1.79.± 0.80 1.55 ±. 0.60
(142 ± 27) (116 + 39) (112 ± 5) (97 ± 37)
B12, ug 4.01 ±. 0.40 3.78 ±. 3.30 4.22.± 1.76 3.00 ±. 2.17
(201 ± 20) (189 ± 165) (211 ± 88) (150 ± 108)
Folate, ug 315 ±. 106 252 ±. 120 286.± 100 237 .± 64
(175 ± 59) (140 ± 67) (159 ± 56) (132 + 36)
Vit C, mg 148.± 89 87 .± 51 152 ±. 59 99 ±. 60
(246 ± 149) (144 ± 86) (254 ± 98) (164 ± 101)
Vit D, ug 4.55 ±. 0.96 10.09 .± 14.7 5.05.± 1.80 3.43 ±. 2.70
(91 ± 19) (202 ± 295) (101 ± 36) (69 ± 54)
Calcium, mg 893 ±. 318 578 ±. 249 848.± 243 584 ±. 169
(112±40) (88 ± 26) (106 ± 30) (73 ± 21)
Copper, mg 1.31 ±. 0.22 1.05 ±. 0.36 1.26.± 0.39 1.06 ±. 0.07
(88 ± 14) (70 ± 24) (84 ± 26) (71 ± 5)
Iron, mg 17.3 ±. 4.4a 11.6 ±. 6.5a,b 14.6 ±. 3.7a,b 9.94.± 0.56b
(173 ± 44) (116 ± 65) (146 ± 37) (99 ± 6)
Magnesium, 338 ±. 105a 276.± 96a,b 319 ±. 35a,b 225 ±. 43b
mg (120 ± 37) (99 ± 34) (114 ± 12) (80 ± 15)
Manganese, mg 3.35 ±. 0.96 2.82 ±. 1.25 3.52 ±. 1.89 2.24 ±. 0.83
(167 ± 48) (141 ± 63) (176 ± 94) (112±42)
Zinc, mg 9.69 ±. 2.10 7.46 ±. 3.29 9.94 ±. 3.73 6.38 ±. 1.61
(81 ± 17) (62 ±27) (83 ± 31) (53 ± 13)
1. LS means ± SEM.
2. Figures in parenthesis are percent RDA/lower limit of ESADDI.
3. Values in a row with different superscripts are significantly significant (p $ 0.05).
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CoPPer. Males in the copper group reported significant increase in folate and zinc
intake from baseline to M2. Females in copper group did not report any significant
changes in nutrient intakes except for a significant decrease in calcium intake from Ml to
M4.
~. Males in the zinc supplemented group reported intakes of vitamin C and
calcium significantly lower at M4 compared to baseline. The intake of vitamin C at M4
was reduced to half the amount consumed at baseline in this group. Females in the zinc
group consumed significantly greater amounts of iron and zinc at eight weeks of
supplementation (M3) compared to baseline. The intake of vitamin C doubled from
baseline to four weeks of supplementation (M2) in this group of females.
Thus, dietary changes over time of particular importance in this group were zinc,
copper, and iron. There were decreases in the intake of copper and zinc in males of the
placebo group, whereas copper consumption increased in females of the placebo group.
There were increases in zinc consumption in males in the copper group unlike males in
the placebo group. Increases in iron intake was reported by females in the zinc group.
Nutrient Density
Nutrient densities (amount of nutrient/WOO kcal) were calculated and compared
for all measurement periods. No significant differences were found in the nutrient
densities between the supplement groups at baseline. There were no significant
differences in nutrient densities between males and females except for protein. The
nutrient density for protein was significantly higher in males (44.9 g/lOOO Kcal)
compared to females (39.2 g/lOOO Kcal). Thus, the quality of the diets were similar for
both the sexes in all the groups at baseline.
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Chan~es Over Time by Gender
Placebo. No significant changes occurred in nutrient densities in males of the
placebo group except for thiamin, vitamin C, and zinc. The nutrient densities for these
nutrients were significantly lower at four weeks supplementation (M2) compared to
baseline. The nutrient density for vitamin C and zinc decreased from M2 to M3 and M4,
but the decreases at M3 and M4 were not significant from M2. Nutrient densities did not
change significantly overtime in females of the placebo group except vitamin A,
riboflavin, B12, and copper. There was a significant increase in the nutrient densities of
these nutrients from baseline to M2. However, nutrient density for copper decreased
significantly from M2 to M3 and the values were similar to baseline at M4. The nutrient
density for zinc decreased significantly (p=O.02) from baseline (7.04 mg/l000 kcal) to
four weeks of supplementation (5.97 mg/l000 kcal) in males in the placebo group.
Females in the placebo group consumed diets with significantly higher nutrient density
for copper at four weeks of supplementation (1.36 mg/ 1000 kcal) compared to baseline
(0.70 mg/lOOO kcal) (p =0.(017). These intakes were greater compared to the findings
of Holden et al. (1979). They reported a mean nutrient density of copper in adult men
and women from a metabolic balance study to be 0.50 mg per 1000 kcal.
Chromium. There were no significant changes over time in the nutrient densities
for females except for fiber in the chromium group. A significant decrease was reported
from baseline to M4 in females in the nutrient density for fiber.
Copper. Significant differences were reported in nutrient densities for males in
the copper group only for vitamin A, B6, and folate. Nutrient densities for these
increased significantly from baseline to four weeks of supplementation. There were no
significant differences in the nutrient densities in females in copper group except for
calcium which was significantly lower at M2 and M4 compared to baseline.
Zinc. No significant differences were observed in the nutrient densities in males
and females in zinc group except for thiamin and vitamin C. The nutrient density for
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thiamin at M4 was significantly greater compared to baseline in females, and the nutrient
density for vitamin C was significantly greater at M2 compared to baseline in females.
Changes Over Time in Anthropometric Measurements
A significant increase in body mass index was found in females in copper group
from baseline to eight weeks of supplementation (p=O.Ol). A significant decrease was
found in body mass index in males in zinc group from baseline to eight weeks of
supplementation (p=O.02). At four weeks of supplementation, males in the copper group
were significantly lighter (mean 75 kg) compared to baseline (mean 80 kg) (p=O.OO15).
A significant decrease in percent body fat was found in males in copper group from
baseline (24 percent) to eight weeks of supplementation (20 percent).
Effects of Trace Mineral Supplementation on Status Measures of Zinc, Copper, and Iron
Anthropometric and biochemical measures in males and females of each of the
supplement groups were compared separately with males and females of the placebo
group. The comparisons were made for each measurement period using Dunnett's
equation. Significant differences were found for males or females of supplemented
groups compared to the placebo group for the biochemical measures for hemoglobin,
serum ferritin, plasma copper, and plasma zinc. No significant differences by gender
were found in anthropometric measures of the supplement group compared to placebo.
Plasma manganese concentrations were not included in the analyses. Our results were
greater than reported values. The anticoagulant used was tested and found to be
contaminated with manganese, thus the values were not used.
The treatment groups are compared with the placebo group (Table 5). Dunnett's
was used separately for males and females to compare each treatment group with the
placebo at every measurement period. The level of significance was set at 0.05.
~
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1. P < 0.05.
2. The direction of arrows represent the values of treatment groups as compared to the placebo group.
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Chromium
The effects of chromium supplementation on status indicators of zinc, copper, and
iron are presented in Table 6. Within the chromium group, serum alkaline phosphatase
decreased significantly (p=O.OOO6) in females from baseline (74.8 U/L) to four weeks
post supplementation (M4) (56.0 U/L). The values decreased steadily from baseline
through M4, but only by M4 did the difference from baseline, M2, and M3 reach
significance. However, this change did not occur in females of the placebo group. While
the values in the chromium group for alkaline phosphatase were not significantly different
from the individual measurement period values in the placebo group, the decrease
overtime in the chromium group alone was significant. No significant changes were
found in albumin and plasma zinc in females due to chromium supplementation. In
women in the placebo group, there also were no changes in albumin or plasma zinc. Our
subjects had initial plasma zinc values closer to the lower limit of the nonna! range. Hahn
and Evans (1975) found a significant effect of zinc supplementation on chromium uptake.
Zinc deficient rats had a significantly higher uptake of chromium compared to zinc replete
rats. It shows that chromium and zinc compete with each other, and zinc absorption is
affected in a depressed zinc status.
Plasma copper increased significantly in females from baseline (8.89 umoVL) to
M3 (11.02 umoVL). A significant decrease was found from eight weeks of
supplementation (M3) to four weeks of post supplementation (M4) (Table 6). However,
no significant changes were found for plasma copper in females of the placebo group.
The changes in plasma copper from baseline to eight weeks of supplementation in the
chromium group were also significantly different from the placebo group (Dunnett's,
Table 5).
Chromium supplementation led to a significant increase in hemoglobin in females
from baseline to M4 (p=O.03) which was not found in females of the placebo group. In
addition, a significant increase in plasma iron was found from M2 to M4 in the chromium
~
















B.sellDe Four Weeks Eight Weeks Four Weeks Baseline Four Weeks Eight Weeks Four Weeks
(M 1) (M 2) (M 3) Post (M 4) (M 1) (M 2) (M 3} Post (M 4)
444 4
4.89 ± 0.16 4.75 ± 0.16 4.65 ± 0.16 5.12 ± 0.16
61.6 ± 4.7 51.9 ± 4.1 51.3 ± 4.1 53.9 ± 4.1
12.2 ± 0.8 11.6 ± 0.5 10.9 ± 0.5 11.3 ± 0.5
6.20 ± 0.80* 6.07 ± 0.80· 5.95 ± 0.66· 6.29 ± 0.66·
15.2 ± 0.4a 16.0 ± 0.48 ,b 16.6 ± 0.4b,· 16.6 ± 0.4b
l00±9 89±9 94±9 88±9





















































15.8 + 1.58 ,b
5 6 6
4.46 + 0.15 4.18 + 0.13 4.31 + 0.12
66.1 + 4.38 67.1 + 3.8a 56.0 + 3.6b
11.4 + 0.5 11.5 + 0.4 11.2 + 0.4
10.31 + 0.68 ,b 11.02 + 0.5b 9.51 + 0.68
14.5 + 0.48 ,b 14.5 + 0.4a,b 15.1 + 0.3b
55 + 8 50+7 55 +7
14.5 + 1.1· 15.1 + l.s8 ,b 18.2 + 1.4b
1. LS Means ± SEM. Alk Phos = Alkaline Phosphatase, Total Hb =Total Hemoglobin. Serum Ferr =Serum Ferritin.
2. Chromium group is compared against Placebo group within gender and measurement period (Dunnett's; p So 0.05).
Differeraa in variables within each row with different symbols (II) ue significantly different (p S 0.05).
3. Rows within supplement groups different alphabetic superscripts ue significantly different (p S O.OS).
4. Vmablea by sex in columns with diffa-ent superscripts (.) are significantly different (p S 0.05).
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group (Table 6). This change did not occur in the females of the placebo group, but the
placebo group was not significantly different from the chromium group at any of the
measurement periods. While serum ferritin decreased from Ml to M3, these changes
were not significant. However, from the Dunnett's equation, a significant difference was
found between females of chromium and placebo groups in serum ferritin at eight weeks
of supplementation (Table 6); the mean serum ferritin of females in the placebo group was
significantly higher than that of the chromium group (Table 5).
The increases in plasma iron and total hemoglobin with a corresponding non-
significant decrease in serum ferritin suggests mobilization of iron from stores due to the
effect of chromium supplementation. This mobilization could be due to increased plasma
copper, because copper helps in synthesis of hemoglobin. Iron is also needed for the
synthesis.
Copper
The effects of copper supplementation on status indicators of zinc, copper, and
iron are presented in Table 7. Copper supplementation did not have any significant effect
on albumin or plasma zinc concentrations in either males or females. However,
significant decreases were found in serum alkaline phosphatase concentrations in both
males and females (Table 7). At four weeks post supplementation, males had
significantly (p=O.Ol) lower concentrations of serum alkaline phosphatase (43.9 U/L)
compared to baseline (60.4 U/L). Similarly, females showed a significant decrease from
baseline (68.3 U/L) to eight weeks (52.9 UIL) and four weeks post supplementation
(43.4 U/L). However, neither males nor females of the placebo group showed any
changes in alkaline phosphatase nor were the values in the copper supplementation group
significantly different from the placebo group for males or females (Dunnett's, Table 5).
No significant changes were found in either males or females over time for plasma
copper. In females in the copper supplementation group, total hemoglobin and plasma
o
I"
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Placebo Copper
N.trlent B.sellDe Four Weeks Eight Weeks Four Weeks Baseline Four Weeks Eight Weeks Four Weeks
<M 1) <M 2) <M 3) Post (M 4) (M 1) (M 2) (M 3) Post (M 4)
Ma.lu. (D) 4 4 4 4 4 4 4 4
AlbumlB, I/dL 4.89 ± 0.16 4.75 ± 0.16 4.65 ± 0.16 5.12 ± 0.16 4.98 ± 0.16 4.72 ± 0.16 4.98 ± 0.16 5.06 ± 0.16
Alk Pbos, 61.6 ± 4.7 51.9 ± 4.7 57.3 ± 4.7 53.9 ± 4.7 60.4 ± 4.7· 51.8 ± 4.7a,b 50.3 ± 4.7a,b 43.9 ± 4.7b
VIL
Plum. ZD, 12.2 ± O.s' 11.6 ± 0.5 10.9 ± 0.5 11.3 ± 0.5 11.9 ± 0.6 12.7 ± 0.6 11.6 ± 0.6 11.0 ± 0.7
umol/L
Pla.ma Cu, 6.20 ± 0.80· 6.07 ± 0.80· 5.95 ± 0.66· 6.29 ± 0.66· 7.65 ± 0.79 7.58 ± 0.66 7.16 ± 0.66 8.44 ± 0.66
amol/L
Tot.1 Ub, 15.2 ± 0.4- 16.0 ± 0.4a,b 16.6 ± 0.4b,· 16.6 ± 0.4b 16.5 ± 0.4· 15.8 ± 0.4· 16.1 ± 0.4· 16.6 ± 0.4-
I/dL
Sera. Ferr, l00±9 89±9 94±9 88±9 152 ± 9· 147 ± 9- 141 ± 9· 144 ± 9-
B.I.L
Plal.a Fe, 13.5 ± 2.2· 15.9 ± 2.2 18.2 ± 1.8 18.9 ± 1.8 21.8 ± 1.8a 15.5 ± l.8b 18.1 ± 1.8a,b 17.8 ± 1.8atb
ulDol/L
Femlle• (.) 3 2 3 3 4 4 4 2
AlbumlD, ./dL 4.66 ± 0.19 5.02 ± 0.24 4.58 ± 0.19 4.94 ± 0.19 4.69 ± 0.16 4.68 ± 0.16 4.40 ± 0.16 5.15 ± 0.25
Alk Pbos, 65.2 ± 5.4 57.4 ± 7.0 59.4 ± 5.4 55.6 ± 5.4 68.3 ± 4.7a 59.5 ± 4.7a,b 52.9 ± 4.7b 43.4 ± 7.2b
U/L
Pi.... Z., 12.8 ± 0.68 12.7 ± 0.8 12.3 ± 0.6 12.8 ± 0.6 11.0 ± 0.6 11.3 ± 0.6 10.7 ± 0.6 11.9 ± 1.2
••oI/L
Pia••• C_, 9.58 ± 0.76·· 8.97 ± 0.98·· 8.58 ± 0.76·· 9.03 ± 0.76·· 8.67 ± 1.00 9.00 ± 0.76 8.50 ± 0.76 8.28 ± 1.47
••oI/L
Total Hb, IS.S ± O.S IS.S ± 0.6 14.9 ± 0.5·- IS.7 ± 0.5 13.4 ± 0.4a-- 14.0 ± 0.4a,b·- 13.3 ± 0.4a,b-- 15.0 ± 0.6b,--I/dL
Sera. Ferr, 97 ± 10 78 ± 13 86± 10 84± 10 35 ± 9-- 30 ±9-- 26±9·- 28 ± 9--
D.I.L
PI•••• Fe, 19.3 ± 2.1·· 18.5 ± 2.7 20.7 ± 2.1 18.9 ± 2.1 21.6 ± 0.4a 15.2 ± 2.1 b 17.7 ± 2.1a,b 24.2 ± 0.4a,b
••oI/L
1. LS MEans ± SEM. A1k Phos = Alkaline Phosphatase, Total Hemoglobin = Total hemoglob~ Serum Ferr = Serum Ferritin.
2. Coppa' group is compared against pl.cebo group within gend« and measurement period (Dwmett's; p So 0.05».
DifJezences in variables within each row with different symbols (#I) ue significantly diffezent (p So 0.05).
3. Rows within supplanent groups with different alphabetic superscripts within each group ue significantly different (p ~ 0.05).
4. Variables by sex in columns with different superscripts (.) ue significantly different (p < O.OS).
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iron increased significantly from baseline to four weeks post supplementation (Table 7).
No significant effects of copper supplementation were found for serum ferritin
concentrations in either males or females. However, in both males and females plasma
iron decreased significantly baseline to four weeks of supplementation suggesting an
initial effect of higher copper intakes. However, plasma iron partially recovered toward
initial concentrations by four weeks post-supplementation period (males) or surpassed
baseline concentrations (females) (Table 7). These changes were not evident in either
males or females of the placebo group.
Dunnett's equation showed that there was a significant difference in values for
serum ferritin concentrations at baseline, four weeks and four weeks of post
supplementation in males (Table 5). Females in the copper group had significantly
different serum ferritin concentrations at all measurement periods compared to females of
the placebo group. Using Dunnett's, plasma copper of the females in copper group at
four weeks of supplementation was significantly different from plasma copper of females
in the placebo group (Table 5). Thus, when plasma copper concentration of the copper
group was compared to the placebo group, four weeks of copper supplementation
affected plasma copper in females although not significantly different from M1 within the
group. Pratt et ale (1985) reported that supplementation with 10 mg of copper for 12
weeks did not affect serum copper concentrations in adults. However, their subjects
were younger (mean age of 46 years) compared to our subjects; their sample was not
divided according to sex; and the mean initial plasma copper concentration was 126 ±22
ug/dL (19.8 umol) which was greater than the baseline means of our study. Bunker et ale
(1984a) also reported higher plasma copper for elderly males (12.7 umo1!L) and elderly
females (14.0 umo1!L) than found in this study. Their mean dietary copper intake was
1.28 ± 0.55 mg/day while in this study mean dietary copper was 1.26 ±0.39 mg/day.
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As expected, zinc supplementation led to a significant increase in plasma zinc in
both males and females. In males, plasma zinc concentrations at four and eight weeks of
supplementation were significantly higher compared to baseline (Table 8). In females the
decrease at M4 was significant as well as the increases at M2 and M3. A similar response
to zinc supplementation was reported by Field et ale (1987). They found that with 100 or
150 mg of zinc/day for four weeks led to a significant increase in plasma zinc from
baseline (11.10 ± 1.85 umol/L) to the end of the supplementation period (14.02 ± 1.55
umol/L). Their controls did not show any significant change over time. They did not find
this response with 50 mg of supplementation. In our study 30 mg of supplementation for
four weeks led to a significant increase in plasma zinc. No significant changes in plasma
zinc was observed in our placebo group from baseline through four weeks post-
supplementation.
The response of our subjects to zinc supplementation could be due to age. It was
hypothesized by Wastney et ale (1992) that the response to zinc loads in the elderly is
greater than is found in younger individuals. The mean basal plasma zinc of their
subjects was 0.86 ± 0.10 mg/L. The baseline values for our subjects (11.0 umollL) were
at the lower end of the nonna! range. Their study identified the changes that occur in zinc
regulation with aging. Our subjects' response to supplemental zinc was similar to that
found by Wastney et ale (1991). In these studies zinc doses which ranged from 30 to 100
mg/d resulted in significant increases in plasma zinc. Samman and Roberts (1987) also
reported a significant increase in plasma zinc in both adult men and women from initial
concentrations when supplemented with 150 mg of zinc for six weeks. Plasma zinc
increased from 15.1 ± 2.5 umollL to 20.6 ± 4.6 umollL in males and from 14.8 ± 2.5 to
23.2 ± 6.3 umollL in females. In our study, males showed a significant increase in
plasma from 11.0 ±0.5 umollL at baseline to 12.9 ±0.6 umol/L at four weeks of
supplementation; a slight increase was found from four to eight weeks of supplementation
('t'l
I"'
rabk 8. Iff"" Q/ zinc 'HllR'cmcnl4tion on status measur,s Q/ zinc. cQRRer. and ironI ,2,3,4
Placebo Zinc
Nutrient Ba.ellne Four Weeks Ellht Week. Four Week. Baseline Four Weeks Ellbt Weeks Four Weeks
(M 1) (M 1) (M 3) Post (M 4) (M 1) (M 1) (M 3) Post (M 4)
M.al.u. (D) 4 4 4 4 4 3 4 4
AlbumlD, I/dL 4.89 ± 0.16 4.15 ± 0.16 4.65 ± 0.16 5.12 ± 0.16 4.18 ± 0.16a,c 5.65 ± 0.20b- 4.61 ± 0.16c 5.21 ± 0.16b
Alit Phos, 61.6 ± 4.7 51.9 ± 4.7 51.3 ± 4.1 53.9 ± 4.1 61.3 ± 4.1a 46.5 ± 5.6b 54.3 ± 4.1a•b 43.1 ± 4.1b-
U/L
Pluma ZD, 12.2 ± 0.8 11.6 ± 0.5 10.9 ± 0.5 11.3 ± 0.5 11.0 ± 0.5a 12.9 ± 0.6b 13.0 ± Oo5b 11.7 ± 0.5··b
ulDol/L
Pla...a Cu, 6.20 ± 0.80· 6.01 ± 0.80· 5.95 ± 0.66· 6.29 ± 0.66· 1.38 ± 0.66 6.46 ± 0.19· 1.91 ± 0.65 7.09 ± 0.65
uDloI/L
Total Ub, aldL 15.2 ± 0.4- 16.0 ± O.48 •b 16.6 ± O.4b• 16.6 ± 0.4b 15.4 ± 0.4 16.6 ± 0.5· 15.7 ± 0.4 16.1 ± 0.4
Seru.. Ferr, l00±9 89±9 94±9 88±9 158 ± 9a• 11S±11b- 104 ± 9b- 114±9b•
D./mL
Plasma Fe, 13.5 ± 2.2· IS.9 ± 2.2 18.2 ± 1.8 18.9 ± 1.8 11.6 ± 1.8 11.0 ± 2.2 19.0 ± 1.8 19.0 ± 1.8
••oI/L
Femlles (D) 3 2 3 3 4 4 4 4
AlbumlD, I/dL 4.66 ± 0.19 5.02 ± 0.24 4.58 ± 0.19 4.94 ± 0.19 4.54 ± 0.16 4.93 ± 0.16·- 4.53 ± 0.16 4.90 ± 0.16
Alit Pbos, 65.2 ± 5.4 51.4 ± 1.0 59.4 ± 5.4 55.6 ± 5.4 61.0 ± 4.1· 50.8 ± 4.1b 62.0 ± 4.1·,b 59.3 ± 4.1··b- *
U/L
Pluma ZB, 12.8 ± 0.68 12.1 ± 0.8 12.3 ± 0.6 12.8 ± 0.6 11.0 ± 0.5· 14.3 ± 0.5b 13.5 ± 0.6b 11.8 ± 0.5·
u.ol/L
Pla...a Cu, 9.58 ± 0.16-· 8.91 ± 0.98·- 8.58 ± 0.16·· 9.03 ± 0.76·· 8.46 ± 0.65 8.95 ± 0.65-· 8.68 ± 0.65 7.90 ± 0.65
••oI/L
Total Ub, I/dL 1505 ± 0.5 15.5 ± 0.6 14.9 ± 0.5·- 15.1 ± 0.5 15.0 ± 0.4 15.2 ± 0.4·· 15.2 ± 0.4 15.5 ± 0.4
Seru. Ferr, 91 ± 10 78 ± 13 86± 10 84± 10 SS ± 9·· 69 ± 9·- SS ±9-· 52±9·*
D./IDL
Plasma Fe, 19.3±2.1·· 1805 ± 2.7 20.1 ± 2.1 18.9 ± 2.1 17.1 ± 1.8 21.1 ± 1.8 20.8 ± 1.8 18.4 ± 1.8
ulDol/L
1. 1.3 Means ± SEM. Alkal PhoI = Alkaline Phosphatase, Total Hb = Total hemoglobin, Serum FerT = Senun Ferritin.
2 Zinc group is compared against pllCebo group within genda' and meuuremenl periods (Dunnett's; p So 0.05).
Differences in variables within elCh row with different symbols (II) are significantly diCCa-ent (p So 0.05).
3. Rows within supplement groups with different alphabetic superscripts are significantly different (p S 0.01).
4. Variable by sex in columns with different superscripts (*) are significantly different (p ~ 0.01).
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which was not significantly different from the four week supplementation value but was
different than initial plasma zinc. Females of our study also showed a significant increase
in plasma zinc concentrations due to zinc supplementation from 11.0 ±0.5 umol/L at
baseline to 14.3 ± 0.5 umol/L at four weeks of supplementation. However, the increase
in our subjects was lower compared to reported findings of Samman and Roberts (1987).
This difference in response could also be due to the amount of dose. Freeland-Graves et
ale (1982) reported a dose dependent increase in plasma zinc. Women supplemented with
100 mg zinc/day for eight weeks showed a greater increase in plasma zinc compared to
women supplemented with 15 or 50 mg of zinc/day. They reported a significant increase
in plasma zinc from initial values in subjects receiving 15, 30, or 100 mg of zinc daily to
four weeks of supplementation. They also found that the plasma zinc in those subjects
declined from four weeks and reached initial values at eight weeks of supplementation.
We found a decrease in plasma zinc from eight weeks to four weeks post supplementation
period which was a discontinuation phase rather than a supplementation phase as reported
by Freeland-Graves et ale (1982). A significant decline was found among females in this
study during the discontinuation phase but the decline in males was not significant. A
significant quadratic effect on plasma zinc due to zinc supplementation was found in the
zinc group (Table 8) which was not found in the placebo group. In a quadratic effect, the
body responds to supplementation with increased absorption leading to an increase and
then decreases after reaching the peak or by withdrawal of the supplement by excretion.
This phenomenon is called homeostasis.
Significant changes in serum zinc in adult women supplemented with zinc were
reported by Yadrick et al. (1989) although they reported no post-supplementation
measures. Serum zinc increased significantly from baseline (12.9 ± 0.6 umol/L) to six
(15.5 ± 0.7 umol/L) and ten weeks of supplementation (16.2 ± 1.1 umol/L). However,
the dose was higher compared to the dose in our study and the initial concentrations were
higher. Fischer et ale (1981) also reported a similar rise in plasma zinc from baseline to
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two weeks of supplementation; no further changes were reported and the values plateaued
at four and six weeks of supplementation. The authors did not provide any values at
baseline or during supplementation.
Both males and females had significantly lower serum alkaline phosphatase
concentrations at four weeks of supplementation compared to baseline (Table 8).
Hambidge and coworkers (1983) also reported a lower mean alkaline phosphatase activity
in pregnant women receiving 15 mg daily compared to controls who did not receive any
supplements. The subjects of the placebo group in our study also did not show any
significant changes in serum alkaline phophatase. Significant differences in albumin with
zinc supplementation were found only in males. Albumin concentrations were
significantly higher at four weeks of supplementation and at four weeks post
supplementation than at baseline. However, there was a significant decrease in albumin
from four to eight weeks of supplementation, and again a significant increase from M3 to
M4 (Table 8). These changes were not found in males of the placebo group. A
contrasting effect of zinc supplementation on albumin was reported by Hambidge et al.
(1983). Mean serum albumin of the pregnant women receiving 15 mg of zinc daily
decreased significantly from 3.8 ± 0.3 g/dL at 3 months to 3.2 ± 0.4 g/dL at 10 months.
In this study the blood was measured every month until delivery. The difference in mean
serum albumin could be due to the physiological demands of pregnancy on these subjects;
also, the duration of supplementation was longer compared to our study.
Zinc supplementation did not have any significant effects on plasma copper in
either males or females. Samman and Roberts (1988) also did not find any significant
effect of zinc on copper. They supplemented adults with 150 mg of zinc and reported no
significant changes. Their dose was higher compared to our study, and the duration was
only six weeks compared to eight weeks in our study. Yadrick et al. (1989) did not fmd
any significant effect with 50 mg of zinc supplementation on ceruloplasmin. However,
they found a significant decrease in Cu-Zn erythrocyte superoxide dismutase from
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pretreatment level to 10 weeks of supplementation. This suggests that superoxide
dismutase is a more sensitive indicator of copper status which is affected at lower zinc
doses than in plasma copper. The researchers who reported a significant decrease in
plasma or serum copper used supplementation levels of over 100 mg/day of zinc unlike
our study.
No significant effects of zinc supplementation were found for hemoglobin and
plasma iron in either males or females in our study. However, a small non-significant
increase in hemoglobin was found in females from baseline compared to M2, M3, and
M4. Similar findings were reported by Yadrick et ale (1989) from a supplementation
study on premenopausal adult women. However, in our study, serum ferritin decreased
significantly in males from baseline to four, eight, and four weeks of post
supplementation. This effect was not found in females (Table 7). Yadrick et ale (1989)
reported a significant decrease in serum ferritin in premenopausal adult females from
baseline (36.6 ± 7.4 ug/L) to ten weeks of supplementation (28.2 ± 5.6 ug/L). They
supplemented adult women with 50 mg of zinc/day for a period of ten weeks. They also
found that pretreatment levels of serum zinc were associated with the change in serum
ferritin during supplementation. A greater decrease in serum ferritin was related to
increased pretreatment levels of serum zinc. Initial plasma zinc concentrations of females
subjects of our study was 11.0 ± 0.5 umol/L (normal: 11.5 - 18.5 umol/L) as compared
to the subjects in the Yadrick study which was 12.9 ±0.6 umol/L.
Differences Between Males and Females in Biochemical Measures at Different
Measurement Periods
Placebo
At all the measurements, males in placebo group had significantly lower
concentrations of plasma copper compared to females. They also had significantly higher
total hemoglobin compared to females at eight weeks of supplementation. No significant
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differences were found between males and females in this group for serum albumin,
alkaline phosphatase, plasma zinc, and plasma iron. Though not significant, females had
higher plasma iron concentrations at Ml, M2, and M3 compared to males (Tables 6-8).
Copper
There were no significant differences between males and females of the copper
supplemented group for albumin, alkaline phosphatase, and plasma minerals. However,
total hemoglobin and serum ferritin concentrations were significantly higher in males
compared to females at all measurement periods. Plasma copper was not significantly
different between males and females (Table 7). However, Bunker et al. (1984a) reported
a difference in plasma copper in different sexes in the elderly. From a metabolic balance
study on elderly subjects consuming self-selected diets, the mean plasma copper levels
for males and females were 12.7 and 14.0 umoVL. Our subjects had lower plasma
copper concentrations, but, like Bunker and co-workers study, mean female plasma
copper concentration was greater than that of males except at four weeks post-
supplementation.
At all the four measurement periods, males had significantly higher serum ferritin
concentrations compared to females. Plasma copper in females was found to be
significantly higher than males at four weeks of supplementation only. At four weeks of
supplementation serum albumin and hemoglobin concentrations were significantly higher
in males compared to females. Alkaline phosphatase was significantly higher in females
compared to males at four weeks post supplementation. However, there were no
significant differences in alkaline phosphatase between males and females at other
measurement periods. No significant differences were found between males and females
in plasma iron and plasma zinc concentrations at any measurement periods (Table 8).
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Regardless of supplement group females had significantly higher concentrations
of plasma copper and plasma iron compared to males. Males had significantly higher




Thirty volunteers over the age 55 years completed this trace mineral
supplementation study conducted in summer of 1993. The purpose of the study was to
investigate the effects of chromium, copper, and zinc supplementation on status indicators
of zinc, copper, and iron. The study was approved by the Institutional Review Board of
Oklahoma State University. An infonned consent was obtained from the subjects prior to
beginning of the study. Infonnation about subjects' health, use of medications, and use
of nutrient supplements was collected at the beginning of the study. Subjects were
trained in keeping three-day food records by a Registered Dietitian.
The subjects were randomly assigned to different treatment groups. For these
analyses the chromium group consisted of only females, while the other groups had both
males and females. The chromium group (females = 6) was supplemented with 241
ug/day of chromium as chromium.chloride; the copper group (males =4; females =4)
was supplemented with 3.8 mg/day of copper as copper carbonate, and zinc group (males
= 4; females = 3) was supplemented with 30.36 mg/day of zinc as zinc sulfate; and the
placebo group (males = 4; females = 3) consumed 0.50 mg of lactose daily. The
supplements were provided in divided doses taken in the morning and evening with
meals. The subjects were supplemented for eight weeks. Fasting blood was collected at
baseline (M1), four weeks of supplementation (M2), eight weeks of supplementation
(M3), and four weeks post supplementation (M4). Three-day food records were kept by
the subjects for all the measurement periods. Subjects were weighed at all the
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measurement periods; however, height was obtained only at baseline and eight weeks of
supplementation.
Plasma minerals were analyzed using atomic absorption spectrophotometry.
Plasma zinc and iron were analyzed by flame with deuterium background correction;
whereas plasma copper and manganese were analyzed on the graphite furnace with
zeeman background correction. In addition to plasma mineral concentrations, serum
albumin, alkaline phosphatase, hemoglobin, and serum ferritin were analyzed as status
measures of zinc, copper, and iron. The SAS General Linear Model (GLM) procedure
was used to test the effects of supplementation over time and interactions between
measurement periods and supplements. Dunnett's test was calculated to compare males
and females of each of the supplement groups separately with males and females of the
placebo group for both anthropometric and biochemical measures. Dietary intakes and
nutrient densities were calculated at all four measurement periods. Changes over time in
nutrient intakes were assessed using the GLM procedure.
When the subjects were divided by gender, no significant differences were found
between the supplement groups for anthopometric and biochemical measures except
hemoglobin and serum ferritin at baseline.
A significant decrease was observed in alkaline phosphatase in females in the
chromium group from baseline to four weeks of supplementation. Chromium
supplementation did not affect albumin or plasma zinc in females. A significant increase
in plasma copper was found from baseline to four weeks of supplementation and also
during the discontinuation phase in females in the chromium group. Hemoglobin
decreased significantly in females in the chromium group from baseline to four weeks
post supplementation. At M4, plasma iron was significantly lower than at baseline in the
chromium group.
Serum alkaline phosphatase concentrations were significantly lower at four weeks
post supplementation than at baseline in both males and females in the copper group. A
81
significant increase in hemoglobin was found in females in the copper group from
baseline to four weeks of supplementation. Both males and females showed significant
decreases in plasma iron from baseline to four weeks of supplementation.
Zinc supplementation did not significantly affect plasma copper in either males or
females. However, zinc supplementation led to a significant increase in plasma zinc after
four weeks of supplementation in both males and females. In females in this group,
plasma zinc decreased significantly during the post supplementattion period. A
significant decrease from baseline values was found for serum alkaline phosphatase in
both males and females at four weeks of supplementation. A significant increase in
albumin after four weeks of supplementation was only found among males in the zinc
group. Serum ferritin levels were significantly lower at M2, M3, and M4 compared to
baseline in males in the zinc group.
A significant decrease for serum alkaline phosphatase was found in all the groups
during the supplementation period. It was hypothesized that alkalaline phosphatase
activity was affected due to bone metabolism. A decrease in the serum alkaline
phosphatase could be related to increased bone metabolism. Since we collected our data
during summer, it can be expected that the subjects were more exposed to sunlight which




The placebo group was found to be different from the supplement groups in
nutrient intakes as well as biochemical measurements. The males in the placebo group
had significantly greater concentrations of plasma zinc compared to males in the copper
and zinc groups at baseline. In addition, males in the placebo group consumed
significantly higher amounts of zinc and copper compared to males in the copper and zinc
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groups. Similarly, females in the placebo group had significantly higher concentrations
of serum ferritin compared to the supplemental groups at baseline. Hence, the acceptance
or rejection of hypotheses was based on the changes that occurred within the supplement
groups only. The effects of supplementation rather than the differences between the
placebo group and the supplement groups as calculated from Dunnett's equation were
considered.
Breakdown of the groups according to gender resulted in very small sample
numbers within each subgroup. This caused problems in statistically analyzing the data.
Changes over time may be important biologically but may also not be apparent
statistically.
Hypothesis one stated that there will be no significant effect of chromium
supplementation on status measures of zinc. We accepted this null hypothesis because
alkaline phosphatase decreased with supplementation and in the post supplementation
period. However, no changes were found in plasma zinc, an indicator of zinc status in
this study due to supplementation (Chapter N, Table 6).
Hypothesis two stated that there will be no significant effect of chromium
supplementation on status measures of copper. This hypothesis was rejected for females
because there was a significant increase in plasma copper in females at eight weeks of
supplementation compared to baseline. Plasma copper decreased significantly from M3
to M4 in the chromium group (chapter N, Table 6). Also, plasma copper levels in the
chromium group at M3 were significantly different from those of the placebo group
(Dunnett's).
Hypothesis three stated that chromium supplementation will not have any
significant effect on status measures of iron. We rejected this hypothesis for females,
because a significant increase in plasma iron was found from baseline to four weeks post
supplementation. A significant increase in hemoglobin from baseline to four weeks post
supplementation was also found in the chromium group (chapter N, Table 6). There
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were no significant differences in serum ferritin levels at different measurement periods.
There were also no significant differences between placebo and chromium groups for
serum ferritin values at any measurement period.
Hypothesis four stated that there will be no significant effect of copper
supplementation on status measures of zinc. No significant changes were found in either
males or females in plasma zinc concentrations in the copper group. Thus, this
hypothesis was accepted for either males and females.
Hypothesis five stated that there will be no significant effect of copper
supplementation on status measures of copper. We accepted this hypothesis for both
males and females since no significant changes over time were found in either males or
females due to copper supplementation. However, from the Dunnett's equation it was
found that at four weeks of supplementation, plasma copper in females of the copper
group were significantly different from females in the placebo group. These
discrepancies in the significant changes in plasma copper in females of the copper group
could be explained with the fact that number of subjects were few, and concentrations
were variable.
Hypothesis six stated that there will be no significant effect of copper
supplementation on status measures of iron. No significant effects were found for serum
ferritin concentrations in either males or females due to copper supplementation. A
significant decrease in plasma iron was found in both males and females from baseline to
four weeks of copper supplementation. In addition, only in females in the copper group
hemoglobin concentration at M4 was significantly greater than at baseline (chapter N,
Table 7). Thus, the hypothesis was rejected for both males and females.
Hypothesis seven stated that there will be no significant effects of zinc
supplementation on status measures of zinc. We found a significant increase in plasma
zinc concentration in both males and females at four and a nearly significant effect (p =
0.0508) at eight weeks of supplementation (chapter N, Table 8). In females in the zinc
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supplemented group, a significant decrease was found from eight weeks of
supplementation to four weeks post supplementation. Thus, a significant quadratic effect
of zinc supplementation on plasma zinc was found. This hypothesis was rejected for
both males and females.
Hypothesis eight stated that zinc supplementation will not significantly affect
status measures of copper. This hypothesis was accepted for both males and females
because no significant changes in plasma copper were found in either males or females
over time due to zinc supplementation.
Hypothesis nine states that there will be no significant effects of zinc
supplementation on status measures of iron. A significant decrease in serum ferritin
concentrations was found in males, but not in females, from baseline to four, eight, and
four weeks post supplementation (chapter IV, Table 8). Thus, we accepted this null
hypothesis for females and rejected it for males.
RECOMMENDAnONS
Based on the results and experience gained in the study, recommendations for further
research were developed by the author.
1. Include a larger sample size to minimize the variability in means of baseline
biochemical and anthopometric measures.
2. Conduct the research separately for males and females of different age groups,
because the Recommended Dietary Allowances are different for males and
females.
3. Supplement the subjects with increased doses to have a greater effect on status
indicators. This will ensure that the intake of the minerals is over the
recommended levels. Higher than the RDA levels are frequently found in
supplements available over-the-counter; the results then will be more applicable to
the elderly populations consuming the nutrient supplements especially iron.
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4. Increase the duration of supplementation giving subjects adequate time to adapt to
higher levels of supplementation.
5 . Compare older subjects with younger subjects to allow a better evaluation of the
effects of supplementation in older people as compared to younger people.
6. Use a nutrient analysis program which contains chromium values or locate
chromium values for key foods and calculate chromium values for recorded
dietaries. This helps in assessing the dietary chromium intake of the subjects
which has a bearing on the effects of chromium supplementation.
7 . Train the subjects in recording consistent and accurate food intakes. This reduces
the mistakes in recording the food intakes and leads to more accurate analysis of
foods for nutrients.
8. Test the anticoagulant as well as all the solutions used for mineral contamination
before using to decrease the potential for contamination.
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LEITER OF RECRUITING ANNOUNCEMENT
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DO YOU HAVB HIGH BLOOD CHOLSSTEROL7
Haw you eftr WOGdcred wba it waWd be lib to be a panicipac ill a resardI SGIdy'!
Would you liD to IalDw die etreas ot aa1rical supJHemeaa oa blood cDo6eSll:ro1. bone
IIIeIabotism aad aucriIiGaI1 sallIS"
We bave aa oppo"",,", for)'OU if you IDeet the foUowUll c:oadiUOftS:
Over die aee of 'j
Nee aUla esuoaea repL1cemalt therapy or was to
coacrot blood dIolcsaaol
Do IIOC bave a dIroaic disease
Blood dlolesterol levels~ UWl 240 mlldl
This smdy is desiped to derermiDe the effect of IDiacnls oa blood lipids., boae metabolism
aDd raeuures of ttxe miDenl swus. The SIUdy iavotves panicipaioa for 12 weela during
wbidl time you wiD panicipare iD body compasitioa IDeISUI'emCIICS (height., weight., skin-fold
mc:aSuremeDa, aIId biodcaric impedaDce), record food inrakes and blood coUecuoQS.
The tim collection period will be ae die begiaaiDg of the stUdy to provide baseline data. For
eig.bt weda you will take a. supplemcm twice a day. The supplement will contain either
1aaDse, l' all ziDc, 1.~ mg copper, 100 uS cbrolDlum or combinacioGS of tJIese concencrations
of c:opper/ziDc or copper/dlromium. DaIa will be coUected after four mc1 eigbt weea of
supplemaatUioa , aDd thea four weeks after the end of supplemematioa.
All dW is reqUired of you is to record food iDtakes for tbree days prior to each dam collection,
take me~ t'fIice daily for eig.bt weeks, aac1 came to me DepartmaK of Nutt'itiooa!
Scicuces 11 OSU u foar week iDrerIaIs for blood coUectioa (30 m1 or about 6 teaspooos).
Weight aad body composition measuremems win be recorded at each data collectioa period.
We ask that you do DO( attI:mpt to lose weight or cbaDge your usual eating aDd exercising
habits during this period.
VolunteerS completing the study will receive a complementary lunch at Taylors Dinning
·Room.
This study has been approved by the Oklahoma State University Internal Review Board for the
protection of human subjects. ·
Sound like faD?!! If you're interested or for further information please contact or tear off
and send this response to:
Andrea B. Arquia, PhD. ROlLO
Janice R. Hermann, PhD, ROlLO
Deparonent of Nutritional Sciences
42.5 HES




I am interested in more information on the blood lipid, bone mineral metabolism and trace





INDNIDUAL'S CONSENT FORM TO PARTICIPATE
IN THE RESEARCH
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lDdividual 's CODSeDt to Participate in Researcl1
Effect of Supplemeatarioa witb Chromium.Copper aDd ZiDc OD Plasma Lipids, BoDe
Metabolism and Indicators of Trace Mineral Status ill Adults
I, , voluntarily agree to participate ill the above titled researcb
which 1$ spoasored by Agncu1ture Experimeztt Station, CoUege of Human Environmemal
Scieaces at Oklaboma Slate University.
I understaDd tbat:
(1) the purpose of the study is to measure the effect of miDeral supplemenlltioa on
plasma lipids, boae metabolism. and SIatUS of orber trace minerals in adults;
(2) I will receive supplemems contaiDiDg either a placebo or ONE of the foUowing
_miDera1S or miDeraJ. combiDatioas wtaicll are equal to or less tbaD those available
ill ol'er-tIIe-coaatcr IIIiDenl supplemeats:
(a) l' mc zinc
(b) 1.5 mg copper
(c) 100 ug chromium
(d) 1~ mg m.c plus 1.5 mg copper
(e) 1.5 mg copper plus 100 ug chromium;
(3) I will take ODe supplement with each morning and evening meal;
(4) 1_tbat these supplelllCllD may cause slight IWISeI if taken OD aD
empty SIOmada aDd dial is the reasoD for the above statemeDl; however, if I
have ..y adv.erse reactioas I will contact ODe of the priDcipal investigators;
(5) I will be requested to record tbree days of food intake four times during this study;
(6) during this study period I should attempt to avoid consumption of oysters, and the
fonowing breakfast cereals: General Mill's Total (all varieties) and Kellogg's
Nutri-grain Raisin Bran, Just Right, and Just Right Froit & Nut;
(7) I will not take any nutrient supplements other than those that are a part of this
study;
(8) a phlebotomist will draw fasting blood samples of 30 m1 (about 6 teaspoons) by
venipuncture prior to the study, at midpoint and end of the supplementation, and
four weeks following supplementation and that slight bruising or discomfort may
result from the venipuncture;
(9) I understand that this blood will only be used for analyses which involve
lipid status, mineral status and bone mineral metabolism and that after these
aaalyscs are performed the remaining blood will be _ and that no
perpetual cellliDcs will be maintained;
(10) as a reward for participation aDd as an incentive to complete the study, I will
receive one coupon for a complimentary luncheon at the Taylor Dining Room at the
end of the study;
97
Time (am/pm)
(11) all records are coafidearial aDd tbat my name will DOC be associated with any
reportS or data records at the eDd of the SIUdy;
(12) participatioo is YolUDtUy aDd tbat I bave the right to witbdraw from this study at
allY time by coaractiDg die priDc:ipa1 investigatOrs;
(13) I will witbdraw from die project if I need to begin raking medication for my
bealth during tbis study;
(14) tbis researdI is beDeficial to me public in tbat many individuals take nuuient
supplemems without knowledge of the iDteractioos among the nutrients; and
(l'l I may CODIICt Dr. Andrea Arquiu or Dr. JaDice HermaDD at (405) 744-S040
sbouId I wish farther information. I may also C01IIICt die office of University
Research Services, 001 Life Scieuces East, Oklahoma State University, Stillwater,
OK 74078 teJepbooe (405) 744-5700.
I have read and fully tmderstand the consent form. I sign it freely and voluntarily. A copy
bas been given to me.
Date _
Signed _
I ceftify mat I have personally explained all elements of tbis form to the subject before





APPROVAL FROM OKLAHOMA STATE UNIVERSITY
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Are you on any type of speci31 diet:
A.llergy
\Ve i gh t loss
Weight gain







Do you currently t3ke any medications on a regular basis? _
Specify all drugs taken
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MON1lILY DATA COLLECTION FORM
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1. H~ve you h:1d :1 cold in the l~st month?
IF YES. when?
how long did it l::lst?
did you h::l ve ::l fever?
H:1ve you h:1d the flu in the l~st month?
IF YES. when
how long did it last?





3. Have you had any other illness last month? Yes _
IF YES. what type of illness?
how long did it (::lst?
did you have :l fever?
~o ---
~. IF YES TO .-\NY OF QUESTIONS - 3, did you continue co take your
supplement during the illness? Yes --- ~o ---
5. Did your exercise p:lttern ch:lnge l:ls[ month? Yes _ ~o ---
IF YES TO QUESTION 5. what way did your e:cercise pattern
change: _
Type of exercise? _
IF YES. how often did you exercise? _















Tim. Amount CQdln; t:.s~:"ipt.i.on:Srand \'anht
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MODIFICAnONS TO BIOCHEMICAL PROCEDURES
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Modifications of the Biochemical Procedures
Total Hemoglobin: The volumes in the procedure were reduced to one half. We used 10
ul of whole blood or lysed erythrocytes and 2.5 ml of Drabkin's solution. Thawed
frozen whole blood or lysed erythrocytes were used. No other modifications to Sigma
procedure # 525 of 1984 were made.
Albumin: Thawed serum was used to measure albumin. Sigma procedure # 625 was
used.
Alkaline Phosphatase: Fresh samples were used to measure alkaline phosphatase on the
same day as phlebotomy. Samples were incubated at room temperature for 45 minutes.
Serum Ferritin: No modifications were made to the procedure supplied by Diagnostic
Products Corporation.
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Frozen plasma samples were thawed for ashing. Two milliliters of plasma were
pipetted into acid washed 13 X 100 mm Borosilicate glass tubes. The sample tubes were
set at 850 C to avoid popping of the samples. Temperature was raised to 9SoC after one
ahour and the temperature was again raised to 10SoC after another hour. To protect the
tubes from environmental contamination, the heating block was placed insida a
polyethylene tank in a fume hood with the lid offset for venting.and allowed to ash for 24
hours until the samples and the blanks were completly dry. Each set of tubes with the
corresponding blanks were placed upright in an inverted acid washed beaker set into an
acid washed petridish lid for dry ashing.
The dry ashing oven was programmed to raise the temperature to 0.50 fmin upto
3750 and maintain the temperature for 1440 minutes (24 hours). The dry ashed samples
were again wet ashed by adding to all the tubes 100 ul of glass distilled water, 100 ul of
double distilled nitric acid, and 100 ul of high purity hidrogen peroxide. These additions
were repeated two more times. The tubes were checked for bubling every ten minutes
before each addition. More hydrogen peroxide (100-200 ul) was added until the bubbling
stopped to ensure thorough ashing. The temperature was gradually increased from 850 C
to 1050 C as explained before. After the samples ashed to dryness (about 24 hours), they
were dry ashed as before. The samples were wet and dry ashed for a total of -four times
to assure complete ashing. The tubes were closed with plastic caps and stored for further
dilution.
Dilution of the Ashe<! Samples
To the ashed plasma, four ml of 0.5% nitric acid was added and vortexed
thoroughly. Plasma manganese was read directly on furnace side of atomic aborption
111
spectrophotometer (AAS) with a fmal dilution of two fold. Plasma zinc and iron were
read on the flame side of the AAS using the dilution factor of four. Plasma copper was
read on the furnace side of the AAS using a 41-dilution.
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